Comprehensive Physiology Wiley Online Library
For Librarians For Authors Editors About

Retinal Physiology and Circulation: Effect of Diabetes

William S. Wright, Randa S. Eshaq, Minsup Lee, Gaganpreet Kaur, Norman R. Harris

10.1002/cphy.c190021

Source: Volume 10, Issue 3, July 2020

Published online: July 2020

Full Article on Wiley Online Library



Abstract

In this article, we present a discussion of diabetes and its complications, including the macrovascular and microvascular effects, with the latter of consequence to the retina. We will discuss the anatomy and physiology of the retina, including aspects of metabolism and mechanisms of oxygenation, with the latter accomplished via a combination of the retinal and choroidal blood circulations. Both of these vasculatures are altered in diabetes, with the retinal circulation intimately involved in the pathology of diabetic retinopathy. The later stages of diabetic retinopathy involve poorly controlled angiogenesis that is of great concern, but in our discussion, we will focus more on several alterations in the retinal circulation occurring earlier in the progression of disease, including reductions in blood flow and a possible redistribution of perfusion that may leave some areas of the retina ischemic and hypoxic. Finally, we include in this article a more recent area of investigation regarding the diabetic retinal vasculature, that is, the alterations to the endothelial surface layer that normally plays a vital role in maintaining physiological functions. © 2020 American Physiological Society. Compr Physiol 10:933‐974, 2020.

Figure 1. Figure 1. Macrovascular and microvascular complications of diabetes. Macrovascular complications include peripheral artery disease, coronary artery disease, and stroke; microvascular complications include diabetic retinopathy, neuropathy, and nephropathy.
Figure 2. Figure 2. Anatomy of the eye. Ocular tissue can be divided into three layers: (1) an outer layer consisting of the sclera and the cornea, (2) an intermediate layer consisting of the iris, the ciliary body, and the choroid, and (3) an internal layer consisting of the retina.
Figure 3. Figure 3. Layers of the retina. The layers of the retina starting from the outermost to the innermost layer are the (1) retinal pigmented epithelium (RPE), (2) photoreceptors (PR), (3) outer limiting membrane (OLM), (4) outer nuclear layer (ONL), (5) outer plexiform layer (OPL), (6) inner nuclear layer (INL), (7) inner plexiform layer (IPL), (8) ganglion cell layer (GCL), (9) nerve fiber layer (NFL), and (10) inner limiting membrane (ILM).
Figure 4. Figure 4. Oxygen sources to the retina. The inner half of the retina receives oxygen from the retinal circulation, while the outer half receives oxygen from the choroidal circulation.
Figure 5. Figure 5. Arterial branches leading to the eye. The blood vessels supplying blood to the inner and outer retina, the iris, and the ciliary body originate from the ophthalmic artery, which is a branch of the internal carotid artery. The ophthalmic artery further divides to give rise to the anterior ciliary arteries, the long and short posterior ciliary arteries, and the central retinal artery.
Figure 6. Figure 6. Retinal microvascular layers. The retinal microcirculatory system can be divided into three distinct layers: (1) the superficial arterioles and venules, (2) the or intermediate capillary layer, and (3) the deep capillary layer.
Figure 7. Figure 7. Transit pathways through the retinal circulation. Normally, most retinal blood flow travels through the deep capillary layer. In diabetic rats, it is possible that a decreased proportion of flow goes through the deep layer, with rapid transit times possibly explained by flow preferentially perfusing the superficial and/or intermediate capillary layers due to vasoconstriction of the vessels (indicated by the asterisks) leading away from the superficial layer.
Figure 8. Figure 8. PECAM‐1 loss may contribute to the development of diabetic retinopathy. Diabetic retinopathy is characterized by leukocyte plugging of capillaries, a decrease in endothelial cell survival, and an increase in vascular leakage. These phenomena also could occur with PECAM‐1 loss, due to its important role in vascular endothelial cell functions.
Figure 9. Figure 9. Glycocalyx components. The structure of the endothelial glycocalyx on the plasma side of the cell includes proteoglycans (such as syndecans and glypican‐1) and glycosaminoglycans (such as heparan sulfate, chondroitin sulfate, and hyaluronic acid).


Figure 1. Macrovascular and microvascular complications of diabetes. Macrovascular complications include peripheral artery disease, coronary artery disease, and stroke; microvascular complications include diabetic retinopathy, neuropathy, and nephropathy.


Figure 2. Anatomy of the eye. Ocular tissue can be divided into three layers: (1) an outer layer consisting of the sclera and the cornea, (2) an intermediate layer consisting of the iris, the ciliary body, and the choroid, and (3) an internal layer consisting of the retina.


Figure 3. Layers of the retina. The layers of the retina starting from the outermost to the innermost layer are the (1) retinal pigmented epithelium (RPE), (2) photoreceptors (PR), (3) outer limiting membrane (OLM), (4) outer nuclear layer (ONL), (5) outer plexiform layer (OPL), (6) inner nuclear layer (INL), (7) inner plexiform layer (IPL), (8) ganglion cell layer (GCL), (9) nerve fiber layer (NFL), and (10) inner limiting membrane (ILM).


Figure 4. Oxygen sources to the retina. The inner half of the retina receives oxygen from the retinal circulation, while the outer half receives oxygen from the choroidal circulation.


Figure 5. Arterial branches leading to the eye. The blood vessels supplying blood to the inner and outer retina, the iris, and the ciliary body originate from the ophthalmic artery, which is a branch of the internal carotid artery. The ophthalmic artery further divides to give rise to the anterior ciliary arteries, the long and short posterior ciliary arteries, and the central retinal artery.


Figure 6. Retinal microvascular layers. The retinal microcirculatory system can be divided into three distinct layers: (1) the superficial arterioles and venules, (2) the or intermediate capillary layer, and (3) the deep capillary layer.


Figure 7. Transit pathways through the retinal circulation. Normally, most retinal blood flow travels through the deep capillary layer. In diabetic rats, it is possible that a decreased proportion of flow goes through the deep layer, with rapid transit times possibly explained by flow preferentially perfusing the superficial and/or intermediate capillary layers due to vasoconstriction of the vessels (indicated by the asterisks) leading away from the superficial layer.


Figure 8. PECAM‐1 loss may contribute to the development of diabetic retinopathy. Diabetic retinopathy is characterized by leukocyte plugging of capillaries, a decrease in endothelial cell survival, and an increase in vascular leakage. These phenomena also could occur with PECAM‐1 loss, due to its important role in vascular endothelial cell functions.


Figure 9. Glycocalyx components. The structure of the endothelial glycocalyx on the plasma side of the cell includes proteoglycans (such as syndecans and glypican‐1) and glycosaminoglycans (such as heparan sulfate, chondroitin sulfate, and hyaluronic acid).
References
 1.Abdouh M, Khanjari A, Abdelazziz N, Ongali B, Couture R, Hasséssian HM. Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin‐diabetic rat. Br J Pharmacol 140: 33‐40, 2003.
 2.Abdouh M, Talbot S, Couture R, Hassessian HM. Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B(1) and B(2) receptors. Br J Pharmacol 154: 136‐143, 2008.
 3.Abu El‐Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132: 551‐556, 2001.
 4.Abu El‐Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye (London, England) 18: 306‐313, 2004.
 5.Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445‐450, 1994.
 6.Adela R, Nethi SK, Bagul PK, Barui AK, Mattapally S, Kuncha M, Patra CR, Reddy PN, Banerjee SK. Hyperglycaemia enhances nitric oxide production in diabetes: A study from South Indian patients. PLoS One 10: e0125270, 2015.
 7.Agardh CD, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin‐dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complicat 6: 96‐100, 1992.
 8.Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon‐carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889‐4894, 1986.
 9.Ahnelt PK, Kolb H. The mammalian photoreceptor mosaic‐adaptive design. Prog Retin Eye Res 19: 711‐777, 2000.
 10.Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL. Vascular endothelial growth factor‐induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta‐isoform‐selective inhibitor. Diabetes 46: 1473‐1480, 1997.
 11.Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 21: 143‐156, 1998.
 12.Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100: 158‐173, 2007.
 13.Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174‐190, 2007.
 14.Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2: a006429, 2012.
 15.Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 97: 889‐891, 1990.
 16.Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM‐1 (endoCAM/CD31): A novel vascular cell‐cell adhesion molecule. J Cell Biol 114: 1059‐1068, 1991.
 17.Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Asymmetrical response of the intraluminal and extraluminal surfaces of the porcine retinal artery to exogenous adenosine. Exp Eye Res 63: 557‐564, 1996.
 18.Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 16: 734‐752, 2009.
 19.Alm A. The effect of sympathetic stimulation on blood flow through t,e uvea, retina and optic nerve in monkeys (Macacca irus). Exp Eye Res 25: 19‐24, 1977.
 20.Alm A, Bill A. Blood flow and oxygen extraction in the cat uvea at normal and high intraocular pressures. Acta Physiol Scand 80: 19‐28, 1970.
 21.Alm A, Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 84: 306‐319, 1972.
 22.Alm A, Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 15: 15‐29, 1973.
 23.Alphonsus CS, Rodseth RN. The endothelial glycocalyx: A review of the vascular barrier. Anaesthesia 69: 777‐784, 2014.
 24.Al‐Shabrawey M, El‐Remessy A, Gu X, Brooks SS, Hamed MS, Huang P, Caldwell RB. Normal vascular development in mice deficient in endothelial NO synthase: Possible role of neuronal NO synthase. Mol Vis 9: 549‐558, 2003.
 25.Al‐Shabrawey M, Rojas M, Sanders T, Behzadian A, El‐Remessy A, Bartoli M, Parpia AK, Liou G, Caldwell RB. Role of NADPH oxidase in retinal vascular inflammation. Invest Ophthalmol Vis Sci 49: 3239‐3244, 2008.
 26.Ames A 3rd, Li YY, Heher EC, Kimble CR. Energy metabolism of rabbit retina as related to function: High cost of Na+ transport. J Neurosci 12: 840‐853, 1992.
 27.Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38: 36‐47, 1997.
 28.Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47: 1953‐1959, 1998.
 29.Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol 124: 15‐26, 2012.
 30.Artwohl M, Brunmair B, Furnsinn C, Holzenbein T, Rainer G, Freudenthaler A, Porod EM, Huttary N, Baumgartner‐Parzer SM. Insulin does not regulate glucose transport and metabolism in human endothelium. Eur J Clin Investig 37: 643‐650, 2007.
 31.Ashton N, Harry J. The pathology of cotton wool spots and cytoid bodies in hypertensive retinopathy and other diseases. Trans Ophthalmol Soc U K 83: 91‐114, 1963.
 32.Astin M, Stjernschantz J, Selen G. Role of nitric oxide in PGF2 alpha‐induced ocular hyperemia. Exp Eye Res 59: 401‐407, 1994.
 33.Aydın A, Orhan H, Sayal A, Özata M, Şahin G, Işımer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control. Clin Biochem 34: 65‐70, 2001.
 34.Ayub T, Khan SN, Ayub SG, Dar R, Andrabi KI. Reduced nitrate level in individuals with hypertension and diabetes. J Cardiovasc Dis Res 2: 172‐176, 2011.
 35.Azmy R, Dawood A, Kilany A, El‐Ghobashy Y, Ellakwa AF, El‐Daly M. Association analysis of genetic variations of eNOS and alpha2beta1 integrin genes with type 2 diabetic retinopathy. Appl Clin Genet 5: 55‐65, 2012.
 36.Badr GA, Tang J, Ismail‐Beigi F, Kern TS. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes 49: 1016‐1021, 2000.
 37.Bae SW, Kim HS, Cha YN, Park YS, Jo SA, Jo I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun 306: 981‐987, 2003.
 38.Balasubramanian R, Gan L. Development of retinal amacrine cells and their dendritic stratification. Curr Ophthalmol Rep 2: 100‐106, 2014.
 39.Ballantyne AJ. The ocular manifestations of spontaneous subarachnoid haemorrhage. Br J Ophthalmol 27: 383‐414, 1943.
 40.Ban CR, Twigg SM, Franjic B, Brooks BA, Celermajer D, Yue DK, McLennan SV. Serum MMP‐7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Res Clin Pract 87: 335‐341, 2010.
 41.Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46: 2210‐2218, 2005.
 42.Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783‐791, 1998.
 43.Barcsay G, Seres A, Nemeth J. The diameters of the human retinal branch vessels do not change in darkness. Invest Ophthalmol Vis Sci 44: 3115‐3118, 2003.
 44.Barnett PA, Gonzalez RG, Chylack LT Jr, Cheng HM. The effect of oxidation on sorbitol pathway kinetics. Diabetes 35: 426‐432, 1986.
 45.Beltramo E, Porta M. Pericyte loss in diabetic retinopathy: Mechanisms and consequences. Curr Med Chem 20: 3218‐3225, 2013.
 46.Benedito S, Prieto D, Nielsen PJ, Nyborg NC. Role of the endothelium in acetylcholine‐induced relaxation and spontaneous tone of bovine isolated retinal small arteries. Exp Eye Res 52: 575‐579, 1991.
 47.Bhat M, Pouliot M, Couture R, Vaucher E. The kallikrein‐kinin system in diabetic retinopathy. Prog Drug Res 69: 111‐143, 2014.
 48.Biallosterski C, van Velthoven ME, Michels RP, Schlingemann RO, DeVries JH, Verbraak FD. Decreased optical coherence tomography‐measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. Br J Ophthalmol 91: 1135‐1138, 2007.
 49.Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, Niehrs C. Wnt induces LRP6 signalosomes and promotes dishevelled‐dependent LRP6 phosphorylation. Science 316: 1619‐1622, 2007.
 50.Bill A. Autonomic nervous control of uveal blood flow. Acta Physiol Scand 56: 70‐81, 1962.
 51.Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye (London, England) 4 (Pt 2): 319‐325, 1990.
 52.Blair NP, Wanek JM, Mori M, Shahidi M. Abnormal retinal vascular oxygen tension response to light flicker in diabetic rats. Invest Ophthalmol Vis Sci 50: 5444‐5448, 2009.
 53.Blaschuk OW, Oshima T, Gour BJ, Symonds JM, Park JH, Kevil CG, Trocha SD, Michaud S, Okayama N, Elrod JW, Alexander JS, Sasaki M. Identification of an occludin cell adhesion recognition sequence. Inflammation 26: 193‐198, 2002.
 54.Bleicher SJ, Lee TY, Bernstein R, Schachter L, Temes R, Krupin T, Santiago J, Becker B, Waltman SR. Effect of blood glucose control on retinal vascular permeability in insulin‐dependent diabetes mellitus. Diabetes Care 3: 184‐186, 1980.
 55.Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 50: 1432‐1439, 2001.
 56.Bolinger MT, Antonetti DA. Moving past anti‐VEGF: Novel therapies for treating diabetic retinopathy. Int J Mol Sci 17: 1498, 2016.
 57.Boulton M, Foreman D, Williams G, McLeod D. VEGF localisation in diabetic retinopathy. Br J Ophthalmol 82: 561‐568, 1998.
 58.Braunagel SC, Xiao JG, Chiou GC. The potential role of adenosine in regulating blood flow in the eye. J Ocul Pharmacol 4: 61‐73, 1988.
 59.Brazitikos PD, Pournaras CJ, Munoz JL, Tsacopoulos M. Microinjection of L‐lactate in the preretinal vitreous induces segmental vasodilation in the inner retina of miniature pigs. Invest Ophthalmol Vis Sci 34: 1744‐1752, 1993.
 60.Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ES, Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53: 2646‐2655, 2010.
 61.Bronson‐Castain KW, Bearse MA Jr, Neuville J, Jonasdottir S, King‐Hooper B, Barez S, Schneck ME, Adams AJ. Adolescents with Type 2 diabetes: Early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina (Philadelphia, Pa) 29: 618‐626, 2009.
 62.Brower JB, Targovnik JH, Caplan MR, Massia SP. High glucose‐mediated loss of cell surface heparan sulfate proteoglycan impairs the endothelial shear stress response. Cytoskeleton (Hoboken) 67: 135‐141, 2010.
 63.Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223‐234, 1995.
 64.Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813‐820, 2001.
 65.Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615‐1625, 2005.
 66.Buerk DG, Riva CE, Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res 52: 13‐26, 1996.
 67.Burg MB, Ferraris JD, Dmitrieva NI. Cellular response to hyperosmotic stresses. Physiol Rev 87: 1441‐1474, 2007.
 68.Bursell SE, Clermont AC, Oren B, King GL. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 36: 596‐607, 1995.
 69.Bursell SE, Clermont AC, Shiba T, King GL. Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Curr Eye Res 11: 287‐295, 1992.
 70.Cabrales P, Vazquez BY, Tsai AG, Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol (1985) 102: 2251‐2259, 2007.
 71.Cai J, Boulton M. The pathogenesis of diabetic retinopathy: Old concepts and new questions. Eye (London, England) 16: 242‐260, 2002.
 72.Cao Y, Feng B, Chen S, Chu Y, Chakrabarti S. Mechanisms of endothelial to mesenchymal transition in the retina in diabetes. Invest Ophthalmol Vis Sci 55: 7321‐7331, 2014.
 73.Capozzi ME, McCollum GW, Cousins DB, Penn JS. Linoleic acid is a diabetes‐relevant stimulator of retinal inflammation in human retinal muller cells and microvascular endothelial cells. J Diabetes Metab 7: 718, 2016.
 74.Carmo A, Cunha‐Vaz JG, Carvalho AP, Lopes MC. l‐Arginine transport in retinas from streptozotocin diabetic rats: Correlation with the level of IL‐1 beta and NO synthase activity. Vis Res 39: 3817‐3823, 1999.
 75.Carmo A, Cunha‐Vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non‐insulin‐dependent diabetic Goto‐Kakizaki rats: Correlation with blood‐retinal barrier permeability. Nitric Oxide Biol Chem 4: 590‐596, 2000.
 76.Chakrabarti S, Gan XT, Merry A, Karmazyn M, Sima AA. Augmented retinal endothelin‐1, endothelin‐3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res 17: 301‐307, 1998.
 77.Chakravarthy U, Hayes RG, Stitt AW, Douglas A. Endothelin expression in ocular tissues of diabetic and insulin‐treated rats. Invest Ophthalmol Vis Sci 38: 2144‐2151, 1997.
 78.Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 47: 945‐952, 1998.
 79.Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14: 285‐294, 1995.
 80.Chast F, Slama G. Apollinaire Bouchardat and diabetes. Hist Sci Med 41: 287‐301, 2007.
 81.Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab 20: 546‐551, 2016.
 82.Chaya T, Matsumoto A, Sugita Y, Watanabe S, Kuwahara R, Tachibana M, Furukawa T. Versatile functional roles of horizontal cells in the retinal circuit. Sci Rep 7: 5540, 2017.
 83.Cheema BS, Kohli HS, Sharma R, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene polymorphism and type 2 diabetic retinopathy among Asian Indians. Acta Diabetol 49: 481‐488, 2012.
 84.Chen Hi HI, Chiang IP, Jen CJ. Exercise training increases acetylcholine‐stimulated endothelium‐derived nitric oxide release in spontaneously hypertensive rats. J Biomed Sci 3: 454‐460, 1996.
 85.Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: Inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat Inflamm 2013: 928315, 2013.
 86.Chen YL, Ren Y, Xu W, Rosa RH Jr, Kuo L, Hein TW. Constriction of retinal venules to endothelin‐1: Obligatory roles of ETA receptors, extracellular calcium entry, and Rho kinase. Invest Ophthalmol Vis Sci 59: 5167‐5175, 2018.
 87.Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK. Aldose reductase deficiency prevents diabetes‐induced blood‐retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54: 3119‐3125, 2005.
 88.Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial PECAM‐1 and its function in vascular physiology and atherogenic pathology. Exp Mol Pathol 100: 409‐415, 2016.
 89.Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138: 271‐281, 2018.
 90.Chong V, Smith RL, Sivaprasad S. Retinal biochemistry, physiology, and cell biology, Chapter 3. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, editors. Retinal Pharmacotherapy. Edinburgh: W.B. Saunders, 2010, p. 15‐22.
 91.Cilensek I, Mankoc S, Globocnik Petrovic M, Petrovic D. The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Mol Biol Rep 39: 7061‐7067, 2012.
 92.Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies. Diabetes Care 26: 2653‐2664, 2003.
 93.Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell SE. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: A potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 124: 433‐446, 1997.
 94.Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell SE. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35: 981‐990, 1994.
 95.Clermont AC, Bursell SE. Retinal blood flow in diabetes. Microcirculation 14: 49‐61, 2007.
 96.Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66: 366‐378, 1961.
 97.Cohan BE, Cohan SB. Flow and oxygen saturation of blood in the anterior ciliary vein of the dog eye. Am J Physiol 205: 60‐66, 1963.
 98.Cohen MP, Surma ML. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes. J Lab Clin Med 98: 715‐722, 1981.
 99.Collins C, Guilluy C, Welch C, O'Brien ET, Hahn K, Superfine R, Burridge K, Tzima E. Localized tensional forces on PECAM‐1 elicit a global mechanotransduction response via the integrin‐RhoA pathway. Curr Biol 22: 2087‐2094, 2012.
 100.Connell P, Walshe T, Ferguson G, Gao W, O'Brien C, Cahill PA. Elevated glucose attenuates agonist‐ and flow‐stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells. Endothelium 14: 17‐24, 2007.
 101.Conway D, Schwartz MA. Lessons from the endothelial junctional mechanosensory complex. F1000 Biol Rep 4: 1, 2012.
 102.Conway DE, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA. Fluid shear stress on endothelial cells modulates mechanical tension across VE‐cadherin and PECAM‐1. Curr Biol 23: 1024‐1030, 2013.
 103.Coppo R, Amore A. Importance of the bradykinin‐nitric oxide synthase system in the hypersensitivity reactions of chronic haemodialysis patients. Nephrol Dial Transplant 15: 1288‐1290, 2000.
 104.Corbalán‐García S, Gómez‐Fernández JC. Protein kinase C regulatory domains: The art of decoding many different signals in membranes. Biochim Biophys Acta 1761: 633‐654, 2006.
 105.Country MW. Retinal metabolism: A comparative look at energetics in the retina. Brain Res 1672: 50‐57, 2017.
 106.Cunha‐Vaz JG, Shakib M, Ashton N. Studies on the permeability of the blood‐retinal barrier. I. On the existence, development, and site of a blood‐retinal barrier. Br J Ophthalmol 50: 441‐453, 1966.
 107.Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol 292: 497‐523, 1990.
 108.Cuthbertson RA, Mandel TE. Anatomy of the mouse retina. Endothelial cell‐pericyte ratio and capillary distribution. Invest Ophthalmol Vis Sci 27: 1659‐1664, 1986.
 109.Dacey DM, Crook JD, Packer OS. Distinct synaptic mechanisms create parallel S‐ON and S‐OFF color opponent pathways in the primate retina. Vis Neurosci 31: 139‐151, 2014.
 110.Daimon M, Sugiyama K, Saitoh T, Yamaguchi H, Hirata A, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Kato T. Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care 23: 559‐560, 2000.
 111.Danialou G, Vicaut E, Sambe A, Aubier M, Boczkowski J. Predominant role of A1 adenosine receptors in mediating adenosine induced vasodilatation of rat diaphragmatic arterioles: Involvement of nitric oxide and the ATP‐dependent K+ channels. Br J Pharmacol 121: 1355‐1363, 1997.
 112.Danser AH, de Vries R, Schoemaker RG, Saxena PR. Bradykinin‐induced release of nitric oxide by the isolated perfused rat heart: Importance of preformed pools of nitric oxide‐containing factors. J Hypertens 16: 239‐244, 1998.
 113.Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT, Schalekamp MA. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35: 1008‐1018, 1994.
 114.Danser AH, van den Dorpel MA, Deinum J, Derkx FH, Franken AA, Peperkamp E, de Jong PT, Schalekamp MA. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 68: 160‐167, 1989.
 115.Dasgupta B, Dufour E, Mamdouh Z, Muller WA. A novel and critical role for tyrosine 663 in platelet endothelial cell adhesion molecule‐1 trafficking and transendothelial migration. J Immunol 182: 5041‐5051, 2009.
 116.Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 74: 741‐751, 1965.
 117.Davis MD. Worsening of diabetic retinopathy after improvement of glycemic control. Arch Ophthalmol 116: 931‐932, 1998.
 118.Davis MD, Blodi BA. Proliferative diabetic retinopathy, Chapter 68. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson CP, editors. Retina (4th ed). Edinburgh: Mosby, 2006, p. 1285‐1322.
 119.Davisson RL, Bates JN, Johnson AK, Lewis SJ. Use‐dependent loss of acetylcholine‐ and bradykinin‐mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide‐containing factors in vascular endothelial cells. Hypertension 28: 354‐360, 1996.
 120.Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 88: 7797‐7801, 1991.
 121.de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 47: 5561‐5568, 2006.
 122.De La Cruz JP, Moreno A, Munoz M, Garcia Campos JM, Sanchez de la Cuesta F. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther 280: 454‐459, 1997.
 123.De La Cruz JP, Moreno A, Ruiz‐Ruiz M, Sanchez De La Cuesta F. Effect of DT‐TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. Thromb Res 97: 125‐131, 2000.
 124.De La Cruz JP, Moreno A, Ruiz‐Ruiz MI, Garcia Campos J, Sanchez de la Cuesta F. Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. Eur J Pharmacol 350: 81‐85, 1998.
 125.de Roetth A. Metabolism of the alloxan diabetic rat retina. Trans Am Ophthalmol Soc 61: 429‐458, 1963.
 126.Dejana E. Endothelial cell‐cell junctions: Happy together. Nat Rev Mol Cell Biol 5: 261‐270, 2004.
 127.Dejana E, Bazzoni G, Lampugnani MG. Vascular endothelial (VE)‐cadherin: Only an intercellular glue? Exp Cell Res 252: 13‐19, 1999.
 128.Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci 126: 2545‐2549, 2013.
 129.Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE‐cadherin in the control of vascular permeability. J Cell Sci 121: 2115‐2122, 2008.
 130.Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 32: 249‐256, 2000.
 131.Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 35: 1289‐1293, 2004.
 132.Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S. Determination of vitreous interleukin‐1 (IL‐1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (London, England) 20: 1366‐1369, 2006.
 133.Dene BA, Maritim AC, Sanders RA, Watkins JB 3rd. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocul Pharmacol Ther 21: 28‐35, 2005.
 134.Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S. Diabetes‐induced vascular dysfunction in the retina: Role of endothelins. Diabetologia 42: 1228‐1234, 1999.
 135.Deng D, Yan N. GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters. Protein Sci 25: 546‐558, 2016.
 136.Desjardins C, Duling BR. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol 258: H647‐H654, 1990.
 137.Deussen A, Sonntag M, Vogel R. L‐arginine‐derived nitric oxide: A major determinant of uveal blood flow. Exp Eye Res 57: 129‐134, 1993.
 138.Devaskar S, Zahm DS, Holtzclaw L, Chundu K, Wadzinski BE. Developmental regulation of the distribution of rat brain insulin‐insensitive (Glut 1) glucose transporter. Endocrinology 129: 1530‐1540, 1991.
 139.Devraj K, Klinger ME, Myers RL, Mokashi A, Hawkins RA, Simpson IA. GLUT‐1 glucose transporters in the blood‐brain barrier: Differential phosphorylation. J Neurosci Res 89: 1913‐1925, 2011.
 140.Diebel LN, Diebel ME, Martin JV, Liberati DM. Acute hyperglycemia exacerbates trauma‐induced endothelial and glycocalyx injury: An in vitro model. J Trauma Acute Care Surg 85: 960‐967, 2018.
 141.Diebel LN, Liberati DM, Martin JV. Acute hyperglycemia increases sepsis related glycocalyx degradation and endothelial cellular injury: A microfluidic study. Am J Surg, 2019.
 142.Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 12: 346‐354, 2012.
 143.Dogne S, Rath G, Jouret F, Caron N, Dessy C, Flamion B. Hyaluronidase 1 deficiency preserves endothelial function and glycocalyx integrity in early streptozotocin‐induced diabetes. Diabetes 65: 2742‐2753, 2016.
 144.Donati G, Pournaras CJ, Munoz JL, Poitry S, Poitry‐Yamate CL, Tsacopoulos M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci 36: 2228‐2237, 1995.
 145.Dorner GT, Garhofer G, Huemer KH, Riva CE, Wolzt M, Schmetterer L. Hyperglycemia affects flicker‐induced vasodilation in the retina of healthy subjects. Vis Res 43: 1495‐1500, 2003.
 146.Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 285: H631‐H636, 2003.
 147.Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35: 1491‐1499, 2003.
 148.Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 287: R735‐R741, 2004.
 149.Du Y, Smith MA, Miller CM, Kern TS. Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80: 771‐779, 2002.
 150.Du Y, Veenstra A, Palczewski K, Kern TS. Photoreceptor cells are major contributors to diabetes‐induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A 110: 16586‐16591, 2013.
 151.Dumskyj MJ, Kohner EM. Retinal blood flow regulation in diabetes mellitus: Impaired autoregulation and No detectable effect of autonomic neuropathy using laser doppler velocimetry, computer assisted image analysis, and isometric exercise. Microvasc Res 57: 353‐356, 1999.
 152.Dwyer KJ, Boado RJ, Pardridge WM. Cis‐element/cytoplasmic protein interaction within the 3′‐untranslated region of the GLUT1 glucose transporter mRNA. J Neurochem 66: 449‐458, 1996.
 153.Ebeling P, Koistinen HA, Koivisto VA. Insulin‐independent glucose transport regulates insulin sensitivity. FEBS Lett 436: 301‐303, 1998.
 154.Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res 116: 1231‐1244, 2015.
 155.Ehrenfeld P, Millan C, Matus CE, Figueroa JE, Burgos RA, Nualart F, Bhoola KD, Figueroa CD. Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J Leukoc Biol 80: 117‐124, 2006.
 156.Elgin SS. Arteriovenous oxygen difference across the uveal tract of the dog eye. Investig Ophthalmol 3: 417‐426, 1964.
 157.Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. Cleavage of syndecan‐1 by membrane type matrix metalloproteinase‐1 stimulates cell migration. J Biol Chem 278: 40764‐40770, 2003.
 158.Eperon G, Johnson M, David NJ. The effect of arterial PO2 on relative retinal blood flow in monkeys. Investig Ophthalmol 14: 342‐352, 1975.
 159.Ernest JT, Goldstick TK, Engerman RL. Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest Ophthalmol Vis Sci 24: 985‐989, 1983.
 160.Eshaq RS, Harris NR. Loss of platelet endothelial cell adhesion molecule‐1 (PECAM‐1) in the diabetic retina: Role of matrix metalloproteinases. Invest Ophthalmol Vis Sci 60: 748‐760, 2019.
 161.Eskens BJ, Zuurbier CJ, van Haare J, Vink H, van Teeffelen JW. Effects of two weeks of metformin treatment on whole‐body glycocalyx barrier properties in db/db mice. Cardiovasc Diabetol 12: 175, 2013.
 162.Espaillat A. Diabetic Eye Disease: A Comprehensive Review. Thorofare, NJ: Slack Incorporated, 2012.
 163.Esser P, Heimann K, Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: Differentiation of subpopulations. Br J Ophthalmol 77: 731‐733, 1993.
 164.Euler T, Haverkamp S, Schubert T, Baden T. Retinal bipolar cells: Elementary building blocks of vision. Nat Rev Neurosci 15: 507‐519, 2014.
 165.Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 33: 601‐607, 2001.
 166.Feenstra DJ, Yego EC, Mohr S. Modes of retinal cell death in diabetic retinopathy. J Clin Exp Ophthalmol 4: 298, 2013.
 167.Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35: 2968‐2975, 1994.
 168.Feke GT, Zuckerman R, Green GJ, Weiter JJ. Response of human retinal blood flow to light and dark. Invest Ophthalmol Vis Sci 24: 136‐141, 1983.
 169.Felder AE, Wanek J, Blair NP, Joslin CE, Brewer KC, Chau FY, Lim JI, Leiderman YI, Shahidi M. The effects of diabetic retinopathy stage and light flicker on inner retinal oxygen extraction fraction. Invest Ophthalmol Vis Sci 57: 5586‐5592, 2016.
 170.Fernandes R, Suzuki K, Kumagai AK. Inner blood‐retinal barrier GLUT1 in long‐term diabetic rats: An immunogold electron microscopic study. Invest Ophthalmol Vis Sci 44: 3150‐3154, 2003.
 171.Ferrari‐Dileo G, Davis EB, Anderson DR. Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci 28: 1747‐1751, 1987.
 172.Ferrari‐Dileo G, Davis EB, Anderson DR. Biochemical evidence for cholinergic activity in retinal blood vessels. Invest Ophthalmol Vis Sci 30: 473‐477, 1989.
 173.Ferrari‐Dileo G, Ryan JW, Rockwood EJ, Davis EB, Anderson DR. Angiotensin‐converting enzyme in bovine, feline, and human ocular tissues. Invest Ophthalmol Vis Sci 29: 876‐881, 1988.
 174.Ferrero E, Ferrero ME, Pardi R, Zocchi MR. The platelet endothelial cell adhesion molecule‐1 (PECAM1) contributes to endothelial barrier function. FEBS Lett 374: 323‐326, 1995.
 175.Ferris FL 3rd, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med 341: 667‐678, 1999.
 176.Ffytche TJ, Bulpitt CJ, Kohner EM, Archer D, Dollery CT. Effect of changes in intraocular pressure on the retinal microcirculation. Br J Ophthalmol 58: 514‐522, 1974.
 177.Fischer F. The first case of diabetic retinopathy. In: von Engelhardt D, editor. Diabetes Its Medical and Cultural History. Berlin, Heidelberg: Springer, 1989, p. 363‐369.
 178.Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and the heart. Eur Heart J 34: 1270‐1278, 2013.
 179.Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM‐1 in the shear‐stress‐induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 118 (Pt 18): 4103‐4111, 2005.
 180.Fleming NBB. Case of retinitis proliferans without history. Proc R Soc Med 21: 1805‐1806, 1928.
 181.Flynn KM, Michaud M, Canosa S, Madri JA. CD44 regulates vascular endothelial barrier integrity via a PECAM‐1 dependent mechanism. Angiogenesis 16: 689‐705, 2013.
 182.Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in diabetes. Diabetes Care 27 (Suppl 1): S84‐S87, 2004.
 183.Förstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. Eur Heart J 33: 829‐837, 837a‐837d, 2012.
 184.Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 26: 77‐82, 2008.
 185.Frank RN. Etiologic mechanisms in diabetic retinopathy, Chapter 66. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson CP, editors. Retina (4th ed). Philadelphia, PA: Elsevier Mosby, 2006, p. 1241‐1270.
 186.Fraser CE, D'Amico DJ. Diabetic retinopathy: Prevention and treatment. In: Post TW, editor. UpToDate. Waltham, MA, p. 7‐17, 2019.
 187.Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T. The blood pressure‐induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244: 1255‐1261, 2006.
 188.Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product‐dependent increase in imidazolium cross‐links in human lens proteins. J Biol Chem 273: 18714‐18719, 1998.
 189.Fuchsjager‐Mayrl G, Malec M, Amoako‐Mensah T, Kolodjaschna J, Schmetterer L. Changes in choroidal blood flow during light/dark transitions are not altered by atropine or propranolol in healthy subjects. Vis Res 43: 2185‐2190, 2003.
 190.Fuchsjager‐Mayrl G, Polska E, Malec M, Schmetterer L. Unilateral light‐dark transitions affect choroidal blood flow in both eyes. Vis Res 41: 2919‐2924, 2001.
 191.Gabbay KH. The sorbitol pathway and the complications of diabetes. N Engl J Med 288: 831‐836, 1973.
 192.Gaede P, Lund‐Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580‐591, 2008.
 193.Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17: 368‐377, 2006.
 194.Gao C, Sun W, Christofidou‐Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ. PECAM‐1 functions as a specific and potent inhibitor of mitochondrial‐dependent apoptosis. Blood 102: 169‐179, 2003.
 195.Garcia‐Ramirez M, Hernandez C, Simo R. Expression of erythropoietin and its receptor in the human retina: A comparative study of diabetic and nondiabetic subjects. Diabetes Care 31: 1189‐1194, 2008.
 196.Garhofer G, Zawinka C, Huemer KH, Schmetterer L, Dorner GT. Flicker light‐induced vasodilatation in the human retina: Effect of lactate and changes in mean arterial pressure. Invest Ophthalmol Vis Sci 44: 5309‐5314, 2003.
 197.Garhofer G, Zawinka C, Resch H, Huemer KH, Dorner GT, Schmetterer L. Diffuse luminance flicker increases blood flow in major retinal arteries and veins. Vis Res 44: 833‐838, 2004.
 198.Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88: 887‐891, 2004.
 199.Garhofer G, Zawinka C, Resch H, Menke M, Schmetterer L, Dorner GT. Effect of intravenous administration of sodium‐lactate on retinal blood flow in healthy subjects. Invest Ophthalmol Vis Sci 44: 3972‐3976, 2003.
 200.Garsen M, Rops AL, Rabelink TJ, Berden JH, van der Vlag J. The role of heparanase and the endothelial glycocalyx in the development of proteinuria. Nephrol Dial Transplant 29: 49‐55, 2014.
 201.GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990‐2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 1659‐1724, 2016.
 202.Gencer S, Cebeci A, Irmak‐Yazicioglu MB. Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines. Chin J Cancer Res 25: 322‐333, 2013.
 203.Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10‐year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54: 3103‐3111, 2005.
 204.Geraldes P, Hiraoka‐Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL. Activation of PKC‐delta and SHP‐1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15: 1298‐1306, 2009.
 205.Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319‐1331, 2010.
 206.Gericke A, Goloborodko E, Sniatecki JJ, Steege A, Wojnowski L, Pfeiffer N. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles. Exp Eye Res 109: 60‐66, 2013.
 207.Gericke A, Wolff I, Musayeva A, Zadeh JK, Manicam C, Pfeiffer N, Li H, Xia N. Retinal arteriole reactivity in mice lacking the endothelial nitric oxide synthase (eNOS) gene. Exp Eye Res 181: 150‐156, 2019.
 208.Geyer O, Neudorfer M, Snir T, Goldstein M, Rock T, Silver DM, Bartov E. Pulsatile ocular blood flow in diabetic retinopathy. Acta Ophthalmol Scand 77: 522‐525, 1999.
 209.Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 107: 1058‐1070, 2010.
 210.Giacco F, Brownlee M. Pathogenesis of microvascular complications. In: Holt RIG, Cockram CS, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes, Hoboken, NJ: Wiley-Blackwell, 2010, p. 553‐574.
 211.Gidday JM, Maceren RG, Shah AR, Meier JA, Zhu Y. KATP channels mediate adenosine‐induced hyperemia in retina. Invest Ophthalmol Vis Sci 37: 2624‐2633, 1996.
 212.Gidday JM, Park TS. Adenosine‐mediated autoregulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci 34: 2713‐2719, 1993.
 213.Giove TJ, Deshpande MM, Gagen CS, Eldred WD. Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy. Mol Vis 15: 2249‐2258, 2009.
 214.Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear‐mitochondrial communication during aging. Cell 155: 1624‐1638, 2013.
 215.Goureau O, Hicks D, Courtois Y, De Kozak Y. Induction and regulation of nitric oxide synthase in retinal Muller glial cells. J Neurochem 63: 310‐317, 1994.
 216.Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM‐1‐deficient mice. J Clin Invest 109: 383‐392, 2002.
 217.Granstam E, Granstam SO. Regulation of uveal and retinal blood flow in STZ‐diabetic and non‐diabetic rats; involvement of nitric oxide. Curr Eye Res 19: 330‐337, 1999.
 218.Granstam E, Granstam SO, Fellstrom B, Lind L. Endothelium‐dependent vasodilation in the uvea of hypertensive and normotensive rats. Curr Eye Res 17: 189‐196, 1998.
 219.Granstam E, Wang L, Bill A. Ocular effects of endothelin‐1 in the cat. Curr Eye Res 11: 325‐332, 1992.
 220.Grunwald JE, Brucker AJ, Schwartz SS, Braunstein SN, Baker L, Petrig BL, Riva CE. Diabetic glycemic control and retinal blood flow. Diabetes 39: 602‐607, 1990.
 221.Guthrie D. The history of diabetes mellitus, 2nd ed., by N. S. Papaspyros, Stuttgart, G. Thieme Verlag, 1964, pp. 104, 10 plates, revised and supplemented, DM. 19.50. Med Hist 9: 198‐198, 1965.
 222.Guthrie MJ, Osswald CR, Kang‐Mieler JJ. Inverse relationship between the intraretinal concentration of bioavailable nitric oxide and blood glucose in early experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 56: 37‐44, 2014.
 223.Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait‐Aissa K, Beyer AM. The human microcirculation: Regulation of flow and beyond. Circ Res 118: 157‐172, 2016.
 224.Guyer DR, Schachat AP, Green WR. The choroid: Structural considerations. In: Hinton DR, editor. Retina. Philadelphia, PA: Elsevier Mosby, 2006, p. 33‐42.
 225.Ha H, Yu MR, Lee HB. High glucose‐induced PKC activation mediates TGF‐beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59: 463‐470, 2001.
 226.Haefliger IO, Flammer J, Lüscher TF. Nitric oxide and endothelin‐1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 33: 2340‐2343, 1992.
 227.Haefliger IO, Meyer P, Flammer J, Lüscher TF. The vascular endothelium as a regulator of the ocular circulation: A new concept in ophthalmology? Surv Ophthalmol 39: 123‐132, 1994.
 228.Hammer M, Vilser W, Riemer T, Mandecka A, Schweitzer D, Kuhn U, Dawczynski J, Liemt F, Strobel J. Diabetic patients with retinopathy show increased retinal venous oxygen saturation. Graefes Arch Clin Exp Ophthalmol 247: 1025‐1030, 2009.
 229.Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 37 (Suppl 1): 39‐43, 2005.
 230.Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51: 3107‐3112, 2002.
 231.Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U. Angiopoietin‐2 causes pericyte dropout in the normal retina: Evidence for involvement in diabetic retinopathy. Diabetes 53: 1104‐1110, 2004.
 232.Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chemtob S. A major role for prostacyclin in nitric oxide‐induced ocular vasorelaxation in the piglet. Circ Res 83: 721‐729, 1998.
 233.Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 47: 5106‐5115, 2006.
 234.Harris A, Bingaman D, Ciulla TA, Martin BJ. Retinal and choroidal blood flow in health and disease. In: Hinton DR, editor. Retina. Philadelphia, PA: Elsevier Mosby, 2006, p. 83‐102.
 235.Harris NR. Arteriovenous pairing: A determinant of capillary exchange. News Physiol Sci 18: 83‐87, 2003.
 236.Harris NR, Leskova W, Kaur G, Eshaq RS, Carter PR. Blood flow distribution and the endothelial surface layer in the diabetic retina. Biorheology 56: 181‐189, 2019.
 237.Harris NR, Watts MN, Leskova W. Intravital video microscopy measurements of retinal blood flow in mice. J Vis Exp: (82): 51110, 2013.
 238.Hawes NL, Smith RS, Chang B, Davisson M, Heckenlively JR, John SW. Mouse fundus photography and angiography: A catalogue of normal and mutant phenotypes. Mol Vis 5: 22, 1999.
 239.Hein TW, Belardinelli L, Kuo L. Adenosine A2A receptors mediate coronary microvascular dilation to adenosine: Role of nitric oxide and ATP‐sensitive potassium channels. J Pharmacol Exp Ther 291: 655‐664, 1999.
 240.Hein TW, Kuo L. cAMP‐independent dilation of coronary arterioles to adenosine : Role of nitric oxide, G proteins, and K(ATP) channels. Circ Res 85: 634‐642, 1999.
 241.Hein TW, Potts LB, Xu W, Yuen JZ, Kuo L. Temporal development of retinal arteriolar endothelial dysfunction in porcine type 1 diabetes. Invest Ophthalmol Vis Sci 53: 7943‐7949, 2012.
 242.Hein TW, Ren Y, Potts LB, Yuan Z, Kuo E, Rosa RH Jr, Kuo L. Acute retinal ischemia inhibits endothelium‐dependent nitric oxide‐mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 53: 30‐36, 2012.
 243.Hein TW, Ren Y, Yuan Z, Xu W, Somvanshi S, Nagaoka T, Yoshida A, Kuo L. Functional and molecular characterization of the endothelin system in retinal arterioles. Invest Ophthalmol Vis Sci 50: 3329‐3336, 2009.
 244.Hein TW, Rosa RH Jr, Yuan Z, Roberts E, Kuo L. Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles. Invest Ophthalmol Vis Sci 51: 1583‐1590, 2010.
 245.Hein TW, Xu W, Kuo L. Dilation of retinal arterioles in response to lactate: Role of nitric oxide, guanylyl cyclase, and ATP‐sensitive potassium channels. Invest Ophthalmol Vis Sci 47: 693‐699, 2006.
 246.Hein TW, Xu W, Xu X, Kuo L. Acute and chronic hyperglycemia elicit JIP1/JNK‐mediated endothelial vasodilator dysfunction of retinal arterioles. Invest Ophthalmol Vis Sci 57: 4333‐4340, 2016.
 247.Hein TW, Yuan Z, Rosa RH Jr, Kuo L. Requisite roles of A2A receptors, nitric oxide, and KATP channels in retinal arteriolar dilation in response to adenosine. Invest Ophthalmol Vis Sci 46: 2113‐2119, 2005.
 248.Hermans MP, Ahn SA, Rousseau MF. eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes. Eur J Clin Investig 42: 729‐737, 2012.
 249.Hester RL, Hammer LW. Venular‐arteriolar communication in the regulation of blood flow. Am J Physiol Regul Integr Comp Physiol 282: R1280‐R1285, 2002.
 250.Hickam JB, Frayser R, Ross JC. A study of retinal venous blood oxygen saturation in human subjects by photographic means. Circulation 27: 375‐385, 1963.
 251.Higashi S, Clermont AC, Dhir V, Bursell SE. Reversibility of retinal flow abnormalities is disease‐duration dependent in diabetic rats. Diabetes 47: 653‐659, 1998.
 252.Higgs GA, Moncada S, Salmon JA, Seager K. The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol 79: 863‐868, 1983.
 253.Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14‐E22, 2001.
 254.Hoeldtke RD, Bryner KD, McNeill DR, Warehime SS, Van Dyke K, Hobbs G. Oxidative stress and insulin requirements in patients with recent‐onset type 1 diabetes. J Clin Endocrinol Metab 88: 1624‐1628, 2003.
 255.Hogan MJ, Feeney L. The ultrastructure of the retinal blood vessels. I. The large vessels. J Ultrastruct Res 39: 10‐28, 1963.
 256.Hookes L. Association for research in vision and ophthalmology (ARVO)—2010 Annual Meeting. For sight: The future of eye and vision research—part 1. IDrugs 13: 427‐429, 2010.
 257.Horio N, Clermont AC, Abiko A, Abiko T, Shoelson BD, Bursell SE, Feener EP. Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine‐induced vasodilatation in normotensive diabetic rats. Diabetologia 47: 113‐123, 2004.
 258.Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF‐alpha: Structure, function and interaction with anti‐TNF agents. Rheumatology (Oxford) 49: 1215‐1228, 2010.
 259.Hoste AM, Boels PJ, Andries LJ, Brutsaert DL, De Laey JJ. Effects of beta‐antagonists on contraction of bovine retinal microarteries in vitro. Invest Ophthalmol Vis Sci 31: 1231‐1237, 1990.
 260.Hoste AM, Boels PJ, Brutsaert DL, De Laey JJ. Effect of alpha‐1 and beta agonists on contraction of bovine retinal resistance arteries in vitro. Invest Ophthalmol Vis Sci 30: 44‐50, 1989.
 261.Housey GM, O'Brian CA, Johnson MD, Kirschmeier P, Weinstein IB. Isolation of cDNA clones encoding protein kinase C: Evidence for a protein kinase C‐related gene family. Proc Natl Acad Sci U S A 84: 1065‐1069, 1987.
 262.Hu YB, Zhang JK, Sun ZY, Yuan ZG, Liu YM, Mao CJ, Yan H. Retinal cell apoptosis, microvascular changes and expression of connective tissue growth factor in experimental diabetic rats. Zhonghua Yan Ke Za Zhi 47: 521‐526, 2011.
 263.Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 273: H2442‐H2451, 1997.
 264.Huber AH, Weis WI. The structure of the beta‐catenin/E‐cadherin complex and the molecular basis of diverse ligand recognition by beta‐catenin. Cell 105: 391‐402, 2001.
 265.Ifuku M, Farber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, Wang B, Cheung G, Ishikawa E, Ooboshi H, Bader M, Wada K, Kettenmann H, Noda M. Bradykinin‐induced microglial migration mediated by B1‐bradykinin receptors depends on Ca2+ influx via reverse‐mode activity of the Na+/Ca2+ exchanger. J Neurosci 27: 13065‐13073, 2007.
 266.Ilan N, Cheung L, Pinter E, Madri JA. Platelet‐endothelial cell adhesion molecule‐1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem 275: 21435‐21443, 2000.
 267.Ilan N, Mahooti S, Rimm DL, Madri JA. PECAM‐1 (CD31) functions as a reservoir for and a modulator of tyrosine‐phosphorylated beta‐catenin. J Cell Sci 112 (Pt 18): 3005‐3014, 1999.
 268.Ilan N, Mohsenin A, Cheung L, Madri JA. PECAM‐1 shedding during apoptosis generates a membrane‐anchored truncated molecule with unique signaling characteristics. FASEB J 15: 362‐372, 2001.
 269.Ilhan F, Kalkanli ST. Atherosclerosis and the role of immune cells. World J Clin Cases 3: 345‐352, 2015.
 270.Illing EK, Gray CH. Retinal metabolism in diabetes; the metabolism of retinae of normal and alloxandiabetic rabbits. J Endocrinol 7: 242‐247, 1951.
 271.Inagaki Y, Yamagishi S, Okamoto T, Takeuchi M, Amano S. Pigment epithelium‐derived factor prevents advanced glycation end products‐induced monocyte chemoattractant protein‐1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia 46: 284‐287, 2003.
 272.Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89: 11059‐11063, 1992.
 273.Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86: 2863‐2867, 1989.
 274.Insull W. The pathology of atherosclerosis: Plaque development and plaque responses to medical treatment. Am J Med 122: S3‐S14, 2009.
 275.Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 30: 601‐606, 1981.
 276.Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44: 2155‐2162, 2003.
 277.Izumi N, Nagaoka T, Mori F, Sato E, Takahashi A, Yoshida A. Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol 50: 465‐468, 2006.
 278.Jean‐Louis S, Lovasik JV, Kergoat H. Systemic hyperoxia and retinal vasomotor responses. Invest Ophthalmol Vis Sci 46: 1714‐1720, 2005.
 279.Jeppesen P, Aalkjaer C, Bek T. Adenosine relaxation in small retinal arterioles requires functional Na‐K pumps and K(ATP) channels. Curr Eye Res 25: 23‐28, 2002.
 280.Jespersen SN, Ostergaard L. The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 32: 264‐277, 2012.
 281.Jiang Q, Ding S, Wu J, Liu X, Wu Z. Norepinephrine stimulates mobilization of endothelial progenitor cells after limb ischemia. PLoS One 9: e101774, 2014.
 282.Johnson EI, Dunlop ME, Larkins RG. Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature. Curr Eye Res 18: 79‐82, 1999.
 283.Joslin EP. Apollinaire Bouchardat 1806–1886. In: von Engelhardt D, editor. Diabetes Its Medical and Cultural History. Berlin, Heidelberg: Springer, 1989, p. 359‐362.
 284.Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte‐mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158: 147‐152, 2001.
 285.Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP. Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐alpha suppression. FASEB J 16: 438‐440, 2002.
 286.Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Retinal vascular endothelial growth factor induces intercellular adhesion molecule‐1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160: 501‐509, 2002.
 287.Kadoglou NP, Sailer N, Fotiadis G, Kapelouzou A, Liapis CD. The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP‐7 and MMP‐8. Exp Clin Endocrinol Diabetes 122: 44‐49, 2014.
 288.Kakei Y, Akashi M, Shigeta T, Hasegawa T, Komori T. Alteration of cell‐cell junctions in cultured human lymphatic endothelial cells with inflammatory cytokine stimulation. Lymphat Res Biol 12: 136‐143, 2014.
 289.Kalantzis G, Angelou M, Poulakou‐Rebelakou E. Diabetic retinopathy: An historical assessment. Hormones (Athens) 5: 72‐75, 2006.
 290.Kalliokoski KK, Knuuti J, Nuutila P. Blood transit time heterogeneity is associated to oxygen extraction in exercising human skeletal muscle. Microvasc Res 67: 125‐132, 2004.
 291.Kandarakis SA, Piperi C, Topouzis F, Papavassiliou AG. Emerging role of advanced glycation‐end products (AGEs) in the pathobiology of eye diseases. Prog Retin Eye Res 42: 85‐102, 2014.
 292.Kato H, Kuriyama N, Duarte S, Clavien P‐A, Busuttil RW, Coito AJ. MMP‐9 deficiency shelters endothelial PECAM‐1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. J Hepatol 60: 1032‐1039, 2014.
 293.Kaur C, Sivakumar V, Foulds WS. Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci 47: 1126‐1141, 2006.
 294.Ke Q, Costa M. Hypoxia‐inducible factor‐1 (HIF‐1). Mol Pharmacol 70: 1469‐1480, 2006.
 295.Kedzierski RM, Yanagisawa M. Endothelin system: The double‐edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851‐876, 2001.
 296.Kellogg DL Jr, Zhao JL, Coey U, Green JV. Acetylcholine‐induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol (1985) 98: 629‐632, 2005.
 297.Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes 50: 1636‐1642, 2001.
 298.Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP. Topical administration of nepafenac inhibits diabetes‐induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56: 373‐379, 2007.
 299.Kevil CG, Oshima T, Alexander B, Coe LL, Alexander JS. H(2)O(2)‐mediated permeability: Role of MAPK and occludin. Am J Physiol Cell Physiol 279: C21‐C30, 2000.
 300.Kiel JW. Choroidal myogenic autoregulation and intraocular pressure. Exp Eye Res 58: 529‐543, 1994.
 301.Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res 69: 413‐429, 1999.
 302.Kiel JW. Anatomy ‐ The ocular circulation. In: Granger DN, Granger JP, editors. The Ocular Circulation. San Rafael, CA: Morgan & Claypool Life Sciences, 2010, p. 3‐10.
 303.Kiel JW, Shepherd AP. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci 33: 2399‐2410, 1992.
 304.Kikuchi‐Utsumi K, Gao B, Ohinata H, Hashimoto M, Yamamoto N, Kuroshima A. Enhanced gene expression of endothelial nitric oxide synthase in brown adipose tissue during cold exposure. Am J Physiol Regul Integr Comp Physiol 282: R623‐R626, 2002.
 305.Kim JH, Kim JH, Yu YS, Cho CS, Kim KW. Blockade of angiotensin II attenuates VEGF‐mediated blood‐retinal barrier breakdown in diabetic retinopathy. J Cereb Blood Flow Metab 29: 621‐628, 2009.
 306.Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y. Role of NAD(P)H oxidase‐ and mitochondria‐derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45: 860‐866, 2005.
 307.Kishi F, Nakaya Y, Ito S. Histamine H2‐receptor‐mediated nitric oxide release from porcine endothelial cells. J Cardiovasc Pharmacol 32: 177‐182, 1998.
 308.Kitada M, Zhang Z, Mima A, King GL. Molecular mechanisms of diabetic vascular complications. J Diabetes Investig 1: 77‐89, 2010.
 309.Kitamura Y, Okamura T, Kani K, Toda N. Nitric oxide‐mediated retinal arteriolar and arterial dilatation induced by substance P. Invest Ophthalmol Vis Sci 34: 2859‐2865, 1993.
 310.Kizub IV, Klymenko KI, Soloviev AI. Protein kinase C in enhanced vascular tone in diabetes mellitus. Int J Cardiol 174: 230‐242, 2014.
 311.Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258‐268, 1995.
 312.Knott RM, Robertson M, Forrester JV. Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture. Diabetologia 36: 808‐812, 1993.
 313.Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 298 (Pt 2): 249‐258, 1994.
 314.Koch KW, Lambrecht HG, Haberecht M, Redburn D, Schmidt HH. Functional coupling of a Ca2+/calmodulin‐dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J 13: 3312‐3320, 1994.
 315.Kojima N, Saito M, Mori A, Sakamoto K, Nakahara T, Ishii K. Role of cyclooxygenase in vasodilation of retinal blood vessels induced by bradykinin in Brown Norway rats. Vasc Pharmacol 51: 119‐124, 2009.
 316.Kolar P. Patophysiology of diabetic retinopathy. Vnitr Lek 59: 173‐176, 2013.
 317.Kolarova H, Ambruzova B, Svihalkova Sindlerova L, Klinke A, Kubala L. Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediat Inflamm 2014: 694312, 2014.
 318.Kondo M, Wang L, Bill A. The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand 75: 232‐235, 1997.
 319.Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, Buzney SM. Retinal blood flow changes in type I diabetes. A long‐term follow‐up study. Invest Ophthalmol Vis Sci 37: 1140‐1148, 1996.
 320.Korbecki J, Baranowska‐Bosiacka I, Gutowska I, Chlubek D. Cyclooxygenase pathways. Acta Biochim Pol 61: 639‐649, 2014.
 321.Koss MC. Role of nitric oxide in maintenance of basal anterior choroidal blood flow in rats. Invest Ophthalmol Vis Sci 39: 559‐564, 1998.
 322.Kowluru RA. Retinal metabolic abnormalities in diabetic mouse: Comparison with diabetic rat. Curr Eye Res 24: 123‐128, 2002.
 323.Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 47: 1594‐1599, 2006.
 324.Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 22: 587‐592, 1997.
 325.Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859‐866, 1998.
 326.Krause M, Rodrigues‐Krause J, O'Hagan C, De Vito G, Boreham C, Susta D, Newsholme P, Murphy C. Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: A preliminary study. Metabolism 61: 1528‐1537, 2012.
 327.Kumagai AK, Vinores SA, Pardridge WM. Pathological upregulation of inner blood‐retinal barrier Glut1 glucose transporter expression in diabetes mellitus. Brain Res 706: 313‐317, 1996.
 328.Kumase F, Morizane Y, Mohri S, Takasu I, Ohtsuka A, Ohtsuki H. Glycocalyx degradation in retinal and choroidal capillary endothelium in rats with diabetes and hypertension. Acta Med Okayama 64: 277‐283, 2010.
 329.Kur J, Newman EA, Chan‐Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 31: 377‐406, 2012.
 330.Laios K, Karamanou M, Saridaki Z, Androutsos G. Aretaeus of Cappadocia and the first description of diabetes. Hormones (Athens) 11: 109‐113, 2012.
 331.Langham ME, Grebe R, Hopkins S, Marcus S, Sebag M. Choroidal blood flow in diabetic retinopathy. Exp Eye Res 52: 167‐173, 1991.
 332.Lantoine F, Iouzalen L, Devynck MA, Millanvoye‐Van Brussel E, David‐Dufilho M. Nitric oxide production in human endothelial cells stimulated by histamine requires Ca2+ influx. Biochem J 330 (Pt 2): 695‐699, 1998.
 333.Laspas P, Goloborodko E, Sniatecki JJ, Kordasz ML, Manicam C, Wojnowski L, Li H, Patzak A, Pfeiffer N, Gericke A. Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice. Exp Eye Res 127: 1‐8, 2014.
 334.Lasta M, Pemp B, Schmidl D, Boltz A, Kaya S, Palkovits S, Werkmeister R, Howorka K, Popa‐Cherecheanu A, Garhofer G, Schmetterer L. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. Invest Ophthalmol Vis Sci 54: 842‐847, 2013.
 335.Laties AM. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol 77: 405‐409, 1967.
 336.Lau JC, Linsenmeier RA. Oxygen consumption and distribution in the diabetic rat retina. Invest Ophthalmol Vis Sci 51: E‐abstract 5644, 2010.
 337.Lau JC, Linsenmeier RA. Increased intraretinal PO2 in short‐term diabetic rats. Diabetes 63: 4338‐4342, 2014.
 338.Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha‐Vaz J, Ambrosio AF, Forrester JV. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood‐retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 5257‐5265, 2007.
 339.Lecleire‐Collet A, Audo I, Aout M, Girmens JF, Sofroni R, Erginay A, Le Gargasson JF, Mohand‐Said S, Meas T, Guillausseau PJ, Vicaut E, Paques M, Massin P. Evaluation of retinal function and flicker light‐induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52: 2861‐2867, 2011.
 340.Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela‐Arispe ML. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691‐703, 2007.
 341.Lee S, Harris NR. Losartan and ozagrel reverse retinal arteriolar constriction in non‐obese diabetic mice. Microcirculation 15: 379‐387, 2008.
 342.Lee S, Morgan GA, Harris NR. Ozagrel reverses streptozotocin‐induced constriction of arterioles in rat retina. Microvasc Res 76: 217‐223, 2008.
 343.Lee SB, Bae IH, Bae YS, Um HD. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem 281: 36228‐36235, 2006.
 344.Leskova W, Pickett H, Eshaq RS, Shrestha B, Pattillo CB, Harris NR. Effect of diabetes and hyaluronidase on the retinal endothelial glycocalyx in mice. Exp Eye Res 179: 125‐131, 2019.
 345.Leskova W, Watts MN, Carter PR, Eshaq RS, Harris NR. Measurement of retinal blood flow rate in diabetic rats: Disparity between techniques due to redistribution of flow. Invest Ophthalmol Vis Sci 54: 2992‐2999, 2013.
 346.Ley K. The role of selectins in inflammation and disease. Trends Mol Med 9: 263‐268, 2003.
 347.Li C, Chen P, Zhang J, Zhang L, Huang X, Yao Y, Che X, Fan X, Ge S, Wang Z. Enzyme‐induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF‐1alpha pathway. Invest Ophthalmol Vis Sci 54: 4964‐4970, 2013.
 348.Li H, Bui BV, Cull G, Wang F, Wang L. Glial cell contribution to basal vessel diameter and pressure‐initiated vascular responses in rat retina. Invest Ophthalmol Vis Sci 58: 1‐8, 2017.
 349.Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, Forstermann U. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107: 2348‐2354, 2003.
 350.Li Q, Puro DG. Adenosine activates ATP‐sensitive K(+) currents in pericytes of rat retinal microvessels: Role of A1 and A2a receptors. Brain Res 907: 93‐99, 2001.
 351.Li Q, Verma A, Han PY, Nakagawa T, Johnson RJ, Grant MB, Campbell‐Thompson M, Jarajapu YP, Lei B, Hauswirth WW. Diabetic eNOS‐knockout mice develop accelerated retinopathy. Invest Ophthalmol Vis Sci 51: 5240‐5246, 2010.
 352.Li W, Yanoff M, Liu X, Ye X. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl) 110: 659‐663, 1997.
 353.Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM‐1. J Exp Med 182: 1337‐1343, 1995.
 354.Lim LS, Ling LH, Ong PG, Foulds W, Tai ES, Wong E, Lee SY, Wong D, Cheung CM, Wong TY. Dynamic responses in retinal vessel caliber with flicker light stimulation in eyes with diabetic retinopathy. Invest Ophthalmol Vis Sci 55: 5207‐5213, 2014.
 355.Limaye V, Li X, Hahn C, Xia P, Berndt MC, Vadas MA, Gamble JR. Sphingosine kinase‐1 enhances endothelial cell survival through a PECAM‐1‐dependent activation of PI‐3K/Akt and regulation of Bcl‐2 family members. Blood 8: 3169‐3177, 2005.
 356.Linsenmeier RA. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 88: 521‐542, 1986.
 357.Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol 99: 177‐197, 1992.
 358.Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA. Retinal hypoxia in long‐term diabetic cats. Invest Ophthalmol Vis Sci 39: 1647‐1657, 1998.
 359.Lipowsky HH. Protease activity and the role of the endothelial glycocalyx in inflammation. Drug Discov Today Dis Model 8: 57‐62, 2011.
 360.Liu J, Feener EP. Plasma kallikrein‐kinin system and diabetic retinopathy. Biol Chem 394: 319‐328, 2013.
 361.Ljungkvist AS, Bussink J, Kaanders JH, van der Kogel AJ. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res 167: 127‐145, 2007.
 362.Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha‐acetylarginine, N alpha‐acetylcysteine, and N alpha‐acetyllysine, and bovine serum albumin. J Biol Chem 269: 32299‐32305, 1994.
 363.Lopez‐Quintero SV, Cancel LM, Pierides A, Antonetti D, Spray DC, Tarbell JM. High glucose attenuates shear‐induced changes in endothelial hydraulic conductivity by degrading the glycocalyx. PLoS One 8: e78954, 2013.
 364.Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive, and resilient. Exp Diabetes Res 2007: 61038, 2007.
 365.Losiewicz MK, Fort PE. Diabetes impairs the neuroprotective properties of retinal alpha‐crystallins. Invest Ophthalmol Vis Sci 52: 5034‐5042, 2011.
 366.Lowry OH, Roberts NR, Lewis C. The quantitative histochemistry of the retina. J Biol Chem 220: 879‐892, 1956.
 367.Lutjen‐Drecoll E. Choroidal innervation in primate eyes. Exp Eye Res 82: 357‐361, 2006.
 368.Ly A, Yee P, Vessey KA, Phipps JA, Jobling AI, Fletcher EL. Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci 52: 9316‐9326, 2011.
 369.Ma ZJ, Chen R, Ren HZ, Guo X, Guo J, Chen LM. Association between eNOS 4b/a polymorphism and the risk of diabetic retinopathy in type 2 diabetes mellitus: A meta‐analysis. J Diabetes Res 2014: 549747, 2014.
 370.MacKinnon JR, O'Brien C, Swa K, Aspinall P, Butt Z, Cameron D. Pulsatile ocular blood flow in untreated diabetic retinopathy. Acta Ophthalmol Scand 75: 661‐664, 1997.
 371.Madge LA, Pober JS. TNF signaling in vascular endothelial cells. Exp Mol Pathol 70: 317‐325, 2001.
 372.Maeda S, Matsui T, Ojima A, Takeuchi M, Yamagishi S. Sulforaphane inhibits advanced glycation end product‐induced pericyte damage by reducing expression of receptor for advanced glycation end products. Nutr Res 34: 807‐813, 2014.
 373.Malecaze F, Clamens S, Simorre‐Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor‐like activity in proliferative diabetic retinopathy. Arch Ophthalmol 112: 1476‐1482, 1994.
 374.Mandecka A, Dawczynski J, Blum M, Muller N, Kloos C, Wolf G, Vilser W, Hoyer H, Muller UA. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30: 3048‐3052, 2007.
 375.Manea SA, Robciuc A, Guja C, Heltianu C. Identification of gene variants in NOS3, ET‐1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects. Biochem Biophys Res Commun 407: 486‐490, 2011.
 376.Marasciulo FL, Montagnani M, Potenza MA. Endothelin‐1: The yin and yang on vascular function. Curr Med Chem 13: 1655‐1665, 2006.
 377.Mariani AP. The neuronal organization of the outer plexiform layer of the primate retina. Int Rev Cytol 86: 285‐320, 1984.
 378.Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin‐induced diabetic mice. Invest Ophthalmol Vis Sci 45: 3330‐3336, 2004.
 379.Massey SC. Functional anatomy of the mammalian retina. In: Hinton DR, editor. Retina. Philadelphia, PA: Elsevier Mosby, vol. 1, 2006, p. 43‐82.
 380.Maurer H, Gerber G. [The central retinal artery of the white laboratory mouse]. Anat Anz 162: 233‐240, 1986.
 381.McClatchey PM, Schafer M, Hunter KS, Reusch JE. The endothelial glycocalyx promotes homogenous blood flow distribution within the microvasculature. Am J Physiol Heart Circ Physiol 311: H168‐H176, 2016.
 382.McLeod D. Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol 89: 229, 2005.
 383.McLeod D, Marshall J, Kohner EM, Bird AC. The role of axoplasmic transport in the pathogenesis of retinal cotton‐wool spots. Br J Ophthalmol 61: 177‐191, 1977.
 384.McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule‐1 and P‐selectin in the diabetic human retina and choroid. Am J Pathol 147: 642‐653, 1995.
 385.Metea MR, Newman EA. Signalling within the neurovascular unit in the mammalian retina. Exp Physiol 92: 635‐640, 2007.
 386.Meyer P, Champion C, Schlotzer‐Schrehardt U, Flammer J, Haefliger IO. Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr Eye Res 18: 375‐380, 1999.
 387.Michel CC, Curry FR. Glycocalyx volume: A critical review of tracer dilution methods for its measurement. Microcirculation 16: 213‐219, 2009.
 388.Minagar A, Alexander JS. Blood‐brain barrier disruption in multiple sclerosis. Mult Scler 9: 540‐549, 2003.
 389.Mishra A, Newman EA. Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia 58: 1996‐2004, 2010.
 390.Mishra A, Newman EA. Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy. Front Neuroenerg 3: 10, 2011.
 391.Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883‐2890, 1996.
 392.Momeni A, Chaleshtori MH, Saadatmand S, Kheiri S. Correlation of endothelial nitric oxide synthase gene polymorphism (GG, TT and GT Genotype) with proteinuria and retinopathy in type 2 diabetic patients. J Clin Diagn Res 10: OC32‐OC35, 2016.
 393.Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341‐355, 2011.
 394.Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44: 4457‐4464, 2003.
 395.Moret P, Pournaras CJ, Munoz JL, Brazitikos P, Tsacopoulos M. Profile of pO2. I. Profile of transretinal pO2 in hypoxia. Klinische Monatsblatter fur Augenheilkunde 200: 498‐499, 1992.
 396.Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Intravenously administered vasodilatory prostaglandins increase retinal and choroidal blood flow in rats. J Pharmacol Sci 103: 103‐112, 2007.
 397.Mori F, King GL, Clermont AC, Bursell DK, Bursell SE. Endothelin‐3 regulation of retinal hemodynamics in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 41: 3955‐3962, 2000.
 398.Moscat J, Diaz‐Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 1: 399‐403, 2000.
 399.Motta G, Rojkjaer R, Hasan AA, Cines DB, Schmaier AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood 91: 516‐528, 1998.
 400.Mukherjee A, Roy S, Saha B, Mukherjee D. Spatio‐temporal regulation of PKC isoforms imparts signaling specificity. Front Immunol 7: 45, 2016.
 401.Muller WA. Leukocyte‐endothelial‐cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24: 327‐334, 2003.
 402.Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 6: 323‐344, 2011.
 403.Muller WA, Weigl SA, Deng X, Phillips DM. PECAM‐1 is required for transendothelial migration of leukocytes. J Exp Med 178: 449‐460, 1993.
 404.Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood‐retinal barrier in diabetic rat retinas. Lab Investig 74: 819‐825, 1996.
 405.Mylona‐Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: A possible link. Pediatr Diabetes 7: 51‐59, 2006.
 406.Nagai N, Izumi‐Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S. Suppression of diabetes‐induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor‐kappaB pathway. Invest Ophthalmol Vis Sci 48: 4342‐4350, 2007.
 407.Naganuma Y, Satoh K, Yi Q, Asazuma N, Yatomi Y, Ozaki Y. Cleavage of platelet endothelial cell adhesion molecule‐1 (PECAM‐1) in platelets exposed to high shear stress. J Thromb Haemost 2: 1998‐2008, 2004.
 408.Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW. C‐reactive protein inhibits endothelium‐dependent nitric oxide‐mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 49: 2053‐2060, 2008.
 409.Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A. The effect of nitric oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci 43: 3037‐3044, 2002.
 410.Nakazawa T, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Vasodilator effects of adenosine on retinal arterioles in streptozotocin‐induced diabetic rats. Naunyn Schmiedeberg's Arch Pharmacol 376: 423‐430, 2008.
 411.Narne P, Ponnaluri KC, Siraj M, Ishaq M. Association analysis of polymorphisms in genes related to oxidative stress in South Indian Type 2 diabetic patients with retinopathy. Ophthalmic Genet 37: 1‐8, 2016.
 412.Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. N Engl J Med 329: 977‐986, 1993.
 413.Nelissen I, Gveric D, van Noort JM, Cuzner ML, Opdenakker G. PECAM‐1 and gelatinase B coexist in vascular cuffs of multiple sclerosis lesions. Neuropathol Appl Neurobiol 32: 15‐22, 2006.
 414.Nesmith BL, Palacio AC, Schaal Y, Gupta A, Schaal S. Diabetes alters the magnitude of vitreomacular adhesion. Retina (Philadelphia, Pa) 37: 749‐752, 2017.
 415.Newman PJ. The role of PECAM‐1 in vascular cell biology. Ann N Y Acad Sci 714: 165‐174, 1994.
 416.Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM‐1: New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23: 953‐964, 2003.
 417.Newton AC. Regulation of the ABC kinases by phosphorylation: Protein kinase C as a paradigm. Biochem J 370: 361‐371, 2003.
 418.Nguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W, Wong TY. Flicker light‐induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32: 2075‐2080, 2009.
 419.Nguyen TT, Shaw JE, Robinson C, Kawasaki R, Wang JJ, Kreis AJ, Wong TY. Diabetic retinopathy is related to both endothelium‐dependent and ‐independent responses of skin microvascular flow. Diabetes Care 34: 1389‐1393, 2011.
 420.Nielsen PJ, Nyborg NC. Contractile and relaxing effects of arachidonic acid derivatives on isolated bovine retinal resistance arteries. Exp Eye Res 50: 305‐311, 1990.
 421.Nieuwdorp M, Holleman F, de Groot E, Vink H, Gort J, Kontush A, Chapman MJ, Hutten BA, Brouwer CB, Hoekstra JB, Kastelein JJ, Stroes ES. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia 50: 1288‐1293, 2007.
 422.Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55: 1127‐1132, 2006.
 423.Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ, Stroes ES. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55: 480‐486, 2006.
 424.Nilsson M, von Wendt G, Wanger P, Martin L. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. Br J Ophthalmol 91: 1596‐1598, 2007.
 425.Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int Suppl 77: S26‐S30, 2000.
 426.Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787‐790, 2000.
 427.Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661‐665, 1988.
 428.Noble KE, Wickremasinghe RG, DeCornet C, Panayiotidis P, Yong KL. Monocytes stimulate expression of the Bcl‐2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol 162: 1376‐1383, 1999.
 429.Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase‐2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 44: 2163‐2170, 2003.
 430.Noyes HD. Retinitis in Glycosuria. Trans Am Ophthalmol Soc 1: 71‐75, 1868.
 431.Nusing R, Lesch R, Ullrich V. Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 3: 53‐58, 1990.
 432.Nussbaum C, Cavalcanti Fernandes Heringa A, Mormanova Z, Puchwein‐Schwepcke AF, Bechtold‐Dalla Pozza S, Genzel‐Boroviczeny O. Early microvascular changes with loss of the glycocalyx in children with type 1 diabetes. J Pediatr 164: 584‐589 e581, 2014.
 433.Nuzum DS, Merz T. Macrovascular complications of diabetes mellitus. J Pharm Pract 22: 135‐148, 2009.
 434.Obrosova IG, Drel VR, Kumagai AK, Szabo C, Pacher P, Stevens MJ. Early diabetes‐induced biochemical changes in the retina: Comparison of rat and mouse models. Diabetologia 49: 2525‐2533, 2006.
 435.Obrosova IG, Fathallah L, Greene DA. Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: Effect of DL‐alpha‐lipoic acid. Eur J Pharmacol 398: 139‐146, 2000.
 436.Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite‐induced protein S‐glutathiolation via disulfide S‐oxide formation. J Biol Chem 276: 29596‐29602, 2001.
 437.Oku H, Kida T, Sugiyama T, Hamada J, Sato B, Ikeda T. Possible involvement of endothelin‐1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina (Philadelphia, Pa) 21: 647‐651, 2001.
 438.Olney JW. An electron microscopic study of synapse formation, receptor outer segment development, and other aspects of developing mouse retina. Investig Ophthalmol 7: 250‐268, 1968.
 439.Omri S, Omri B, Savoldelli M, Jonet L, Thillaye‐Goldenberg B, Thuret G, Gain P, Jeanny JC, Crisanti P, Behar‐Cohen F. The outer limiting membrane (OLM) revisited: Clinical implications. Clin Ophthalmol 4: 183‐195, 2010.
 440.Osawa M, Masuda M, Kusano K, Fujiwara K. Evidence for a role of platelet endothelial cell adhesion molecule‐1 in endothelial cell mechanosignal transduction: Is it a mechanoresponsive molecule? J Cell Biol 158: 773‐785, 2002.
 441.Osborne NN, Barnett NL, Herrera AJ. NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res 610: 194‐198, 1993.
 442.Ostergaard L, Kristiansen SB, Angleys H, Frokiaer J, Michael Hasenkam J, Jespersen SN, Botker HE. The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease. Basic Res Cardiol 109: 409, 2014.
 443.Otani S, Nagaoka T, Omae T, Tanano I, Kamiya T, Ono S, Hein TW, Kuo L, Yoshida A. Histamine‐induced dilation of isolated porcine retinal arterioles: Role of endothelium‐derived hyperpolarizing factor. Invest Ophthalmol Vis Sci 57: 4791‐4798, 2016.
 444.Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711‐1717, 1989.
 445.Ozden S, Tatlipinar S, Bicer N, Yaylali V, Yildirim C, Ozbay D, Guner G. Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol 38: 393‐396, 2003.
 446.Page‐McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221‐233, 2007.
 447.Pahwa R, Nallasamy P, Jialal I. Toll‐like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J Diabetes Complicat 30: 563‐572, 2016.
 448.Paques M, Tadayoni R, Sercombe R, Laurent P, Genevois O, Gaudric A, Vicaut E. Structural and hemodynamic analysis of the mouse retinal microcirculation. Invest Ophthalmol Vis Sci 44: 4960‐4967, 2003.
 449.Park JW, Park SJ, Park SH, Kim KY, Chung JW, Chun MH, Oh SJ. Up‐regulated expression of neuronal nitric oxide synthase in experimental diabetic retina. Neurobiol Dis 21: 43‐49, 2006.
 450.Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL. Induction of endothelin‐1 expression by glucose: An effect of protein kinase C activation. Diabetes 49: 1239‐1248, 2000.
 451.Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, Oh SJ. Apoptotic death of photoreceptors in the streptozotocin‐induced diabetic rat retina. Diabetologia 46: 1260‐1268, 2003.
 452.Parver LM, Auker C, Carpenter DO. Choroidal blood flow as a heat dissipating mechanism in the macula. Am J Ophthalmol 89: 641‐646, 1980.
 453.Parver LM, Auker CR, Carpenter DO. The stabilizing effect of the choroidal circulation on the temperature environment of the macula. Retina (Philadelphia, Pa) 2: 117‐120, 1982.
 454.Patel JI, Saleh GM, Hykin PG, Gregor ZJ, Cree IA. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (London, England) 22: 223‐228, 2008.
 455.Patel SA, Simon MC. Biology of hypoxia‐inducible factor‐2alpha in development and disease. Cell Death Differ 15: 628‐634, 2008.
 456.Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. BMJ (Clinical research ed) 305: 678‐683, 1992.
 457.Paterno R, Faraci FM, Heistad DD. Role of Ca(2+)‐dependent K+ channels in cerebral vasodilatation induced by increases in cyclic GMP and cyclic AMP in the rat. Stroke 27: 1603‐1607; discussion 1607‐1608, 1996.
 458.Pemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M, Schmetterer L. Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci 50: 4029‐4032, 2009.
 459.Phipps JA, Feener EP. The kallikrein‐kinin system in diabetic retinopathy: Lessons for the kidney. Kidney Int 73: 1114‐1119, 2008.
 460.Pinna A, Emanueli C, Dore S, Salvo M, Madeddu P, Carta F. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. Ophthalmologica 218: 260‐263, 2004.
 461.Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin‐1. Exp Eye Res 76: 633‐640, 2003.
 462.Polak K, Schmetterer L, Riva CE. Influence of flicker frequency on flicker‐induced changes of retinal vessel diameter. Invest Ophthalmol Vis Sci 43: 2721‐2726, 2002.
 463.Popov D. Endothelial cell dysfunction in hyperglycemia: Phenotypic change, intracellular signaling modification, ultrastructural alteration, and potential clinical outcomes. Int J Diabetes Mellit 2: 189‐195, 2010.
 464.Potts LB, Bradley PD, Xu W, Kuo L, Hein TW. Role of endothelium in vasomotor responses to endothelin system and protein kinase C activation in porcine retinal arterioles. Invest Ophthalmol Vis Sci 54: 7587‐7594, 2013.
 465.Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP. Insulin‐like growth factor‐I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165: 457‐469, 2004.
 466.Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Acute intensive insulin therapy exacerbates diabetic blood‐retinal barrier breakdown via hypoxia‐inducible factor‐1alpha and VEGF. J Clin Invest 109: 805‐815, 2002.
 467.Pouliot M, Talbot S, Senecal J, Dotigny F, Vaucher E, Couture R. Ocular application of the kinin B1 receptor antagonist LF22‐0542 inhibits retinal inflammation and oxidative stress in streptozotocin‐diabetic rats. PLoS One 7: e33864, 2012.
 468.Pournaras C, Tsacopoulos M, Chapuis P. Studies on the role of prostaglandins in the regulation of retinal blood flow. Exp Eye Res 26: 687‐697, 1978.
 469.Pournaras CJ. Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies. Retina (Philadelphia, Pa) 15: 332‐347, 1995.
 470.Pournaras CJ, Riva CE, Tsacopoulos M, Strommer K. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res 49: 347‐360, 1989.
 471.Pournaras CJ, Rungger‐Brandle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27: 284‐330, 2008.
 472.Powell ED, Field RA. Diabetic retinopathy and rheumatoid arthritis. Lancet 2: 17‐18, 1964.
 473.Pricci F, Leto G, Amadio L, Iacobini C, Cordone S, Catalano S, Zicari A, Sorcini M, Di Mario U, Pugliese G. Oxidative stress in diabetes‐induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic Biol Med 35: 683‐694, 2003.
 474.Privratsky JR, Paddock CM, Florey O, Newman DK, Muller WA, Newman PJ. Relative contribution of PECAM‐1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci 124 (Pt 9): 1477‐1485, 2011.
 475.Pruneau D, Belichard P, Sahel JA, Combal JP. Targeting the kallikrein‐kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 11: 507‐514, 2010.
 476.Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, Zhao HL. The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta‐analysis. PLoS One 12: e0176157, 2017.
 477.Rajah TT, Olson AL, Grammas P. Differential glucose uptake in retina‐ and brain‐derived endothelial cells. Microvasc Res 62: 236‐242, 2001.
 478.Rask‐Madsen C, King GL. Differential regulation of VEGF signaling by PKC‐alpha and PKC‐epsilon in endothelial cells. Arterioscler Thromb Vasc Biol 28: 919‐924, 2008.
 479.Rask‐Madsen C, King GL. Vascular complications of diabetes: Mechanisms of injury and protective factors. Cell Metab 17: 20‐33, 2013.
 480.Razandi M, Pedram A, Rubin T, Levin ER. PGE2 and PGI2 inhibit ET‐1 secretion from endothelial cells by stimulating particulate guanylate cyclase. Am J Physiol 270: H1342‐H1349, 1996.
 481.Reddy VS, Raghu G, Reddy SS, Pasupulati AK, Suryanarayana P, Reddy GB. Response of small heat shock proteins in diabetic rat retina. Invest Ophthalmol Vis Sci 54: 7674‐7682, 2013.
 482.Reine TM, Grondahl F, Jenssen TG, Hadler‐Olsen E, Prydz K, Kolset SO. Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice. J Histochem Cytochem 61: 606‐616, 2013.
 483.Reine TM, Lanzalaco F, Kristiansen O, Enget AR, Satchell S, Jenssen TG, Kolset SO. Matrix metalloproteinase‐9 mediated shedding of syndecan‐4 in glomerular endothelial cells. Microcirculation 26: e12534, 2019.
 484.Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch 454: 345‐359, 2007.
 485.Remington LA, Remington LA. Retina, Chapter 4. In: Falk K, Hart CM editors. Clinical Anatomy and Physiology of the Visual System (3rd ed). Saint Louis: Butterworth‐Heinemann, 2012, p. 61‐92.
 486.Rho YH, Solus J, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 63: 535‐541, 2011.
 487.Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31: 986‐1000, 2011.
 488.Rimmer T, Linsenmeier RA. Resistance of diabetic rat electroretinogram to hypoxemia. Invest Ophthalmol Vis Sci 34: 3246‐3252, 1993.
 489.Riva CE, Grunwald JE, Petrig BL. Reactivity of the human retinal circulation to darkness: A laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 24: 737‐740, 1983.
 490.Riva CE, Grunwald JE, Petrig BL. Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci 27: 1706‐1712, 1986.
 491.Riva CE, Grunwald JE, Sinclair SH. Laser Doppler Velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci 24: 47‐51, 1983.
 492.Riva CE, Logean E, Falsini B. Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res 24: 183‐215, 2005.
 493.Riva CE, Logean E, Petrig BL, Falsini B. Effect of dark adaptation on retinal blood flow. Klinische Monatsblatter fur Augenheilkunde 216: 309‐310, 2000.
 494.Riva CE, Pournaras CJ, Tsacopoulos M. Regulation of local oxygen tension and blood flow in the inner retina during hyperoxia. J Appl Physiol (1985) 61: 592‐598, 1986.
 495.Riva CE, Sinclair SH, Grunwald JE. Autoregulation of retinal circulation in response to decrease of perfusion pressure. Invest Ophthalmol Vis Sci 21: 34‐38, 1981.
 496.Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A. Inhibition of platelet endothelial cell adhesion molecule‐1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF‐alpha and IFN‐gamma. J Immunol 157: 1233‐1241, 1996.
 497.Robertson PL, Ar D, Goldstein GW. Phosphoinositide metabolism and prostacyclin formation in retinal microvascular endothelium: Stimulation by adenine nucleotides. Exp Eye Res 50: 37‐44, 1990.
 498.Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 27: 722‐726, 1986.
 499.Romer LH, McLean NV, Yan HC, Daise M, Sun J, DeLisser HM. IFN‐gamma and TNF‐alpha induce redistribution of PECAM‐1 (CD31) on human endothelial cells. J Immunol 154: 6582‐6592, 1995.
 500.Roy S, Amin S. Retinal fibrosis in diabetic retinopathy. Exp Eye Res 142: 71‐75, 2016.
 501.Ruiz‐Loredo AY, López‐Colomé AM. New insights into the regulation of myosin light chain phosphorylation in retinal pigment epithelial cells, Chapter 3. In: Jeon KW, editor. International Review of Cell and Molecular Biology. San Diego, CA: Academic Press, 2012, p. 85‐121.
 502.Ryan SJ, Puliafito CA, Davis JL, Parel J‐M, Milne P, Ryan S, Moshiri A. Functional Anatomy of the Mammalian Retina, Chapter 4. In: Ryan SJ, Hinton DR, Schachat AP, and Wilkinson CP, editors. Retina. Philadelphia, PA: Elsevier Mosby, 2006, p. 43‐82.
 503.Sachs UJ, Andrei‐Selmer CL, Maniar A, Weiss T, Paddock C, Orlova VV, Choi EY, Newman PJ, Preissner KT, Chavakis T, Santoso S. The neutrophil‐specific antigen CD177 is a counter‐receptor for platelet endothelial cell adhesion molecule‐1 (CD31). J Biol Chem 282: 23603‐23612, 2007.
 504.Samra YA, Saleh HM, Hussein KA, Elsherbiny NM, Ibrahim AS, Elmasry K, Fulzele S, El‐Shishtawy MM, Eissa LA, Al‐Shabrawey M, Liou GI. Adenosine deaminase‐2‐induced hyperpermeability in human retinal vascular endothelial cells is suppressed by microRNA‐146b‐3p. Invest Ophthalmol Vis Sci 58: 933‐943, 2017.
 505.Sanes JR, Masland RH. The types of retinal ganglion cells: Current status and implications for neuronal classification. Annu Rev Neurosci 38: 221‐246, 2015.
 506.Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Relationship of endothelial nitric oxide synthase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophthalmic Genet 33: 23‐27, 2012.
 507.Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson‐Berka JL. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 163: 879‐887, 2003.
 508.Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 4504‐4509, 2004.
 509.Sawa Y, Sugimoto Y, Ueki T, Ishikawa H, Sato A, Nagato T, Yoshida S. Effects of TNF‐alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J Histochem Cytochem 55: 721‐733, 2007.
 510.Schaefer S, Kajimura M, Tsuyama S, Uchida K, Sato E, Inoue M, Suematsu M, Watanabe K. Aberrant utilization of nitric oxide and regulation of soluble guanylate cyclase in rat diabetic retinopathy. Antioxid Redox Signal 5: 457‐465, 2003.
 511.Schafer M, Schafer C, Ewald N, Piper HM, Noll T. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 92: 1010‐1015, 2003.
 512.Schenkel AR, Chew TW, Muller WA. Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J Immunol 10: 6403‐6408, 2004.
 513.Schmetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, Adam H, Eichler HG, Wolzt M. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 46: 653‐658, 1997.
 514.Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521‐1528, 1994.
 515.Schmidt KG, von Ruckmann A, Kemkes‐Matthes B, Hammes HP. Ocular pulse amplitude in diabetes mellitus. Br J Ophthalmol 84: 1282‐1284, 2000.
 516.Schneider MP, Boesen EI, Pollock DM. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 47: 731‐759, 2007.
 517.Schocket LS, Brucker AJ, Niknam RM, Grunwald JE, DuPont J, Brucker AJ. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol 25: 89‐94, 2004.
 518.Schreiber V. EDRF‐NO. The endothelium‐derived relaxing factor is nitric oxide. Cas Lek Cesk 131: 388‐390, 1992.
 519.Schroder S, Palinski W, Schmid‐Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139: 81‐100, 1991.
 520.Semenza GL. HIF‐1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985) 88: 1474‐1480, 2000.
 521.Semeraro F, Cancarini A, dell'omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: Vascular and inflammatory disease. J Diabetes Res 2015: 582060, 2015.
 522.Sena CM, Pereira AM, Seiça R. Endothelial dysfunction ‐ A major mediator of diabetic vascular disease. Biochim Biophys Acta 1832: 2216‐2231, 2013.
 523.Shafat I, Ilan N, Zoabi S, Vlodavsky I, Nakhoul F. Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels. PLoS One 6: e17312, 2011.
 524.Sharma M, Jamieson C, Johnson M, Molloy MP, Henderson BR. Specific armadillo repeat sequences facilitate β‐catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem 287: 819‐831, 2012.
 525.Sharma S, Saxena S, Srivastav K, Shukla RK, Mishra N, Meyer CH, Kruzliak P, Khanna VK. Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations. Clin Exp Ophthalmol 43: 429‐436, 2015.
 526.Sharma SD, Pandey BN, Mishra KP, Sivakami S. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro. J Biochem Mol Biol Biophys 6: 233‐242, 2002.
 527.Shaw SK, Perkins BN, Lim YC, Liu Y, Nusrat A, Schnell FJ, Parkos CA, Luscinskas FW. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule‐1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor‐α plus interferon‐γ does not reduce leukocyte transmigration under flow. Am J Pathol 6: 2281‐2291, 2001.
 528.Sheikpranbabu S, Haribalaganesh R, Gurunathan S. Pigment epithelium‐derived factor inhibits advanced glycation end‐products‐induced cytotoxicity in retinal pericytes. Diabetes Metab 37: 505‐511, 2011.
 529.Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265: E783‐E793, 1993.
 530.Shitashige M, Satow R, Honda K, Ono M, Hirohashi S, Yamada T. Regulation of Wnt signaling by the nuclear pore complex. Gastroenterology 134: 1961‐1971, 1971.e1961‐1964, 2008.
 531.Shu J, Santulli G. Heparanase in health and disease: The neglected housekeeper of the cell? Atherosclerosis 283: 124‐126, 2019.
 532.Simmons RA, Polin RA, Abman SH, Rowitch DH, Benitz WE, Fox WW. Cell glucose transport and glucose handling during fetal and neonatal development, Chapter 43. In: Polin RA, Abman SH, Rowitch D, Benitz WE, Fox WW, editors. Fetal and Neonatal Physiology (5th ed). Philadelphia, PA: Elsevier, 2017, p. 428‐435.e423.
 533.Sinclair SH, Grunwald JE, Riva CE, Braunstein SN, Nichols CW, Schwartz SS. Retinal vascular autoregulation in diabetes mellitus. Ophthalmology 89: 748‐750, 1982.
 534.Singh A, Friden V, Dasgupta I, Foster RR, Welsh GI, Tooke JE, Haraldsson B, Mathieson PW, Satchell SC. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Ren Physiol 300: F40‐F48, 2011.
 535.Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18: 1‐14, 2014.
 536.Sjolie AK, Dodson P, Hobbs FR. Does renin‐angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int J Clin Pract 65: 148‐153, 2011.
 537.Small KW, Stefansson E, Hatchell DL. Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci 28: 672‐675, 1987.
 538.Smith RS, John SWM, Nishina PM. The posterior segment and orbit. In: John SWM, Nishina PM, Sundberg JP, editors. Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. Boca Raton, FL: CRC Press LLC: Taylor & Francis Group, 2002, p. 25‐44.
 539.Smith RS, Rudt LA. Ocular vascular and epithelial barriers to microperoxidase. Investig Ophthalmol 14: 556‐560, 1975.
 540.Sogawa K, Nagaoka T, Izumi N, Nakabayashi S, Yoshida A. Acute hyperglycemia‐induced endothelial dysfunction in retinal arterioles in cats. Invest Ophthalmol Vis Sci 51: 2648‐2655, 2010.
 541.Someya E, Akagawa M, Mori A, Morita A, Yui N, Asano D, Sakamoto K, Nakahara T. Role of neuron–glia signaling in regulation of retinal vascular tone in rats. Int J Mol Sci 20: 1952, 2019.
 542.Sone H, Deo BK, Kumagai AK. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci 41: 1876‐1884, 2000.
 543.Song HB, Jun HO, Kim JH, Yu YS, Kim KW. Suppression of protein kinase C‐ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy. Biochem Biophys Res Commun 444: 63‐68, 2014.
 544.Song Y, Nagaoka T, Yoshioka T, Nakabayashi S, Tani T, Yoshida A. Role of glial cells in regulating retinal blood flow during flicker‐induced hyperemia in cats. Invest Ophthalmol Vis Sci 56: 7551‐7559, 2015.
 545.Sorrentino FS, Matteini S, Bonifazzi C, Sebastiani A, Parmeggiani F. Diabetic retinopathy and endothelin system: Microangiopathy versus endothelial dysfunction. Eye (London, England) 32: 1157‐1163, 2018.
 546.Starr CR, Engleberg NC. Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infect Immun 74: 40‐48, 2006.
 547.Starr MS. Effects of prostaglandin on blood flow in the rabbit eye. Exp Eye Res 11: 161‐169, 1971.
 548.Stefansson E, Hatchell DL, Fisher BL, Sutherland FS, Machemer R. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol 101: 657‐664, 1986.
 549.Stefansson E, Peterson JI, Wang YH. Intraocular oxygen tension measured with a fiber‐optic sensor in normal and diabetic dogs. Am J Physiol 256: H1127‐H1133, 1989.
 550.Stefansson E, Wagner HG, Seida M. Retinal blood flow and its autoregulation measured by intraocular hydrogen clearance. Exp Eye Res 47: 669‐678, 1988.
 551.Stepniak E, Radice GL, Vasioukhin V. Adhesive and signaling functions of cadherins and catenins in vertebrate development. Cold Spring Harb Perspect Biol 1: a002949, 2009.
 552.Stewart RJ, Kashour TS, Marsden PA. Vascular endothelial platelet endothelial adhesion molecule‐1 (PECAM‐1) expression is decreased by TNF‐alpha and IFN‐gamma. Evidence for cytokine‐induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 156: 1221‐1228, 1996.
 553.Stjernschantz J, Alm A, Bill A. Effects of intracranial oculomotor nerve stimulation on ocular blood flow in rabbits: Modification by indomethacin. Exp Eye Res 23: 461‐469, 1976.
 554.Stjernschantz J, Bill A. Vasomotor effects of facial nerve stimulation: Noncholinergic vasodilation in the eye. Acta Physiol Scand 109: 45‐50, 1980.
 555.Stjernschantz J, Geijer C, Bill A. Electrical stimulation of the fifth cranial nerve in rabbits: Effects on ocular blood flow, extravascular albumin content and intraocular pressure. Exp Eye Res 28: 229‐238, 1979.
 556.Su EN, Alder VA, Yu DY, Yu PK, Cringle SJ, Yogesan K. Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long‐term study of streptozotocin‐induced diabetes in rats. Graefes Arch Clin Exp Ophthalmol 238: 163‐173, 2000.
 557.Su J, An XR, Li Q, Li XX, Cong XD, Xu M. Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET‐1/Nox4 signal pathway in diabetic rats. Sci Rep 8: 12620, 2018.
 558.Suarez G, Rajaram R, Oronsky AL, Gawinowicz MA. Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose. J Biol Chem 264: 3674‐3679, 1989.
 559.Sullivan DP, Rüffer C, Muller WA. Isolation of the lateral border recycling compartment using a diaminobenzidine‐induced density shift. Traffic 15: 1016‐1029, 2014.
 560.Sutherland FS, Stefansson E, Hatchell DL, Reiser H. Retinal oxygen consumption in vitro. The effect of diabetes mellitus, oxygen and glucose. Acta Ophthalmol (Copenh) 68: 715‐720, 1990.
 561.Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, Clermont AC, King GL. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin‐1. Invest Ophthalmol Vis Sci 37: 2504‐2518, 1996.
 562.Takagi C, King GL, Clermont AC, Cummins DR, Takagi H, Bursell SE. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha‐glucosidase inhibitor. Curr Eye Res 14: 741‐749, 1995.
 563.Takagi H, King GL, Aiello LP. Hypoxia upregulates glucose transport activity through an adenosine‐mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47: 1480‐1488, 1998.
 564.Takei K, Sato T, Nonoyama T, Miyauchi T, Goto K, Hommura S. A new model of transient complete obstruction of retinal vessels induced by endothelin‐1 injection into the posterior vitreous body in rabbits. Graefes Arch Clin Exp Ophthalmol 231: 476‐481, 1993.
 565.Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 30: 343‐358, 2011.
 566.Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol 2013: 343560, 2013.
 567.Tattersall R. Diabetes: The Biography. Oxford University Press, 2009, 240 pp.
 568.Taylor E, Dobree JH. Proliferative diabetic retinopathy. Site and size of initial lesions. Br J Ophthalmol 54: 11‐18, 1970.
 569.Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The “metabolic memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients 9: 437, 2017.
 570.The Vision Health Initiative (VHI). Retinal conditions — Common eye disorders. 2014. https://www.cdc.gov/media/pressrel/2010/r101022.html, accessed 22 October 2010.
 571.Thomas B, Caballero B. Diabetes mellitus: Secondary complications. In: Caballero B, Finglas P, Toldra F, editors. Encyclopedia of Food Sciences and Nutrition (2nd ed). Oxford: Academic Press, 2003, p. 1800‐1804.
 572.Tikhonenko M, Lydic TA, Wang Y, Chen W, Opreanu M, Sochacki A, McSorley KM, Renis RL, Kern T, Jump DB, Reid GE, Busik JV. Remodeling of retinal Fatty acids in an animal model of diabetes: A decrease in long‐chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59: 219‐227, 2010.
 573.Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38: 1258‐1270, 1989.
 574.Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, Antonetti DA. Novel atypical PKC inhibitors prevent vascular endothelial growth factor‐induced blood‐retinal barrier dysfunction. Biochem J 446: 455‐467, 2012.
 575.Toda N, Kitamura Y, Okamura T. Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol 266: H1985‐H1992, 1994.
 576.Tonade D, Liu H, Kern TS. Photoreceptor cells produce inflammatory mediators that contribute to endothelial cell death in diabetes. Invest Ophthalmol Vis Sci 57: 4264‐4271, 2016.
 577.Tornquist P, Alm A. Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand 106: 351‐357, 1979.
 578.Trick GL, Berkowtiz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res 24: 259‐274, 2005.
 579.Trudeau K, Molina AJ, Guo W, Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: Implications for diabetic retinopathy. Am J Pathol 177: 447‐455, 2010.
 580.Tsacopoulos M, Baker R, Johnson M, Strauss J, David NJ. The effect of arterial PCO2 on inner‐retinal oxygen availability in monkeys. Investig Ophthalmol 12: 449‐455, 1973.
 581.Tsacopoulos M, David NJ. The effect of arterial PCO2 on relative retinal blood flow in monkeys. Investig Ophthalmol 12: 335‐347, 1973.
 582.Tzima E, Irani‐Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437: 426‐431, 2005.
 583.UK Prospective Diabetes Study (UKPDS) Group. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837‐853, 1998.
 584.Ullrich V, Zou MH, Bachschmid M. New physiological and pathophysiological aspects on the thromboxane A(2)‐prostacyclin regulatory system. Biochim Biophys Acta 1532: 1‐14, 2001.
 585.van den Hoven MJ, Rops AL, Bakker MA, Aten J, Rutjes N, Roestenberg P, Goldschmeding R, Zcharia E, Vlodavsky I, van der Vlag J, Berden JH. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int 70: 2100‐2108, 2006.
 586.van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Verbraak FD, Abramoff MD. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 50: 3404‐3409, 2009.
 587.Van Geest RJ, Leeuwis JW, Dendooven A, Pfister F, Bosch K, Hoeben KA, Vogels IM, Van der Giezen DM, Dietrich N, Hammes HP, Goldschmeding R, Klaassen I, Van Noorden CJ, Schlingemann RO. Connective tissue growth factor is involved in structural retinal vascular changes in long‐term experimental diabetes. J Histochem Cytochem 62: 109‐118, 2014.
 588.Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol 48: 307‐320, 1986.
 589.Venkataraman ST, Hudson C, Fisher JA, Flanagan JG. Novel methodology to comprehensively assess retinal arteriolar vascular reactivity to hypercapnia. Microvasc Res 72: 101‐107, 2006.
 590.Venturini CM, Knowles RG, Palmer RM, Moncada S. Synthesis of nitric oxide in the bovine retina. Biochem Biophys Res Commun 180: 920‐925, 1991.
 591.Vergès B. Pathophysiology of diabetic dyslipidaemia: Where are we? Diabetologia 58: 886‐899, 2015.
 592.Vials A, Burnstock G. A2‐purinoceptor‐mediated relaxation in the guinea‐pig coronary vasculature: A role for nitric oxide. Br J Pharmacol 109: 424‐429, 1993.
 593.Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79: 581‐589, 1996.
 594.Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical demonstration of blood‐retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium. Histochem J 25: 648‐663, 1993.
 595.Vogl‐Willis CA, Edwards IJ. High‐glucose‐induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim Biophys Acta 1672: 36‐45, 2004.
 596.Wagner JD, Cann JA, Zhang L, Harwood HJ, Abee CR, Mansfield K, Tardif S, Morris T. Diabetes and obesity research using nonhuman primates, Chapter 14. In: Abee C, Mansfield K, Tardif S, Morris T editors. Nonhuman Primates in Biomedical Research (2nd ed). Boston, MA: Academic Press, 2012, p. 699‐732.
 597.Wakabayashi Y, Usui Y, Okunuki Y, Takeuchi M, Kezuka T, Iwasaki T, Goto H. Increased levels of monokine induced by interferon‐gamma (Mig) in the vitreous of patients with diabetic retinopathy. Diabet Med 25: 875‐877, 2008.
 598.Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331‐367, 1999.
 599.Wanek J, Teng PY, Blair NP, Shahidi M. Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats. Invest Ophthalmol Vis Sci 55: 1588‐1593, 2014.
 600.Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez‐Vivar J, Gutterman DD, Widlansky ME. Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: Role for AMP kinase. Arterioscler Thromb Vasc Biol 32: 712‐720, 2012.
 601.Wang L, Fortune B, Cull G, McElwain KM, Cioffi GA. Microspheres method for ocular blood flow measurement in rats: Size and dose optimization. Exp Eye Res 84: 108‐117, 2007.
 602.Wang L, Grant C, Fortune B, Cioffi GA. Retinal and choroidal vasoreactivity to altered PaCO2 in rat measured with a modified microsphere technique. Exp Eye Res 86: 908‐913, 2008.
 603.Wang S, Villegas‐Perez MP, Vidal‐Sanz M, Lund RD. Progressive optic axon dystrophy and vacuslar changes in Rd mice. Invest Ophthalmol Vis Sci 41: 537‐545, 2000.
 604.Wang W, Sawicki G, Schulz R. Peroxynitrite‐induced myocardial injury is mediated through matrix metalloproteinase‐2. Cardiovasc Res 53: 165‐174, 2002.
 605.Wang Z, Yadav AS, Leskova W, Harris NR. Attenuation of streptozotocin‐induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan. Exp Eye Res 91: 670‐675, 2010.
 606.Wang Z, Yadav AS, Leskova W, Harris NR. Inhibition of 20‐HETE attenuates diabetes‐induced decreases in retinal hemodynamics. Exp Eye Res 93: 108‐113, 2011.
 607.Wangsa‐Wirawan ND, Linsenmeier RA. Retinal oxygen: Fundamental and clinical aspects. Arch Ophthalmol 121: 547‐557, 2003.
 608.Wardle EN. Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 23: 135‐139, 1994.
 609.Watanabe T, Matsushima S, Okazaki M, Nagamatsu S, Hirosawa K, Uchimura H, Nakahara K. Localization and ontogeny of GLUT3 expression in the rat retina. Brain Res Dev Brain Res 94: 60‐66, 1996.
 610.Watt SM, Gschmeissner SE, Bates PA. PECAM‐1: Its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk Lymphoma 17: 229‐244, 2009.
 611.Wheeler‐Schilling TH, Kohler K, Sautter M, Guenther E. Angiotensin II receptor subtype gene expression and cellular localization in the retina and non‐neuronal ocular tissues of the rat. Eur J Neurosci 11: 3387‐3394, 1999.
 612.Wilkinson‐Berka JL. Vasoactive factors and diabetic retinopathy: Vascular endothelial growth factor, cycoloxygenase‐2 and nitric oxide. Curr Pharm Des 10: 3331‐3348, 2004.
 613.Williams B, Gallacher B, Patel H, Orme C. Glucose‐induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46: 1497‐1503, 1997.
 614.Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801‐813, 1993.
 615.Winkler BS, Starnes CA, Sauer MW, Firouzgan Z, Chen SC. Cultured retinal neuronal cells and Muller cells both show net production of lactate. Neurochem Int 45: 311‐320, 2004.
 616.Winkler JL, Kedees MH, Guz Y, Teitelman G. Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy. Mol Vis 18: 874‐886, 2012.
 617.Winn RK, Harlan JM. The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 3: 1815‐1824, 2005.
 618.Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc 54: 729‐826, 1956.
 619.Wisniewska‐Kruk J, Klaassen I, Vogels IM, Magno AL, Lai CM, Van Noorden CJ, Schlingemann RO, Rakoczy EP. Molecular analysis of blood‐retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Exp Eye Res 122: 123‐131, 2014.
 620.Woodfin A, Reichel CA, Khandoga A, Corada M, Voisin MB, Scheiermann C, Haskard DO, Dejana E, Krombach F, Nourshargh S. JAM‐A mediates neutrophil transmigration in a stimulus‐specific manner in vivo: Evidence for sequential roles for JAM‐A and PECAM‐1 in neutrophil transmigration. Blood 110: 1848‐1856, 2007.
 621.Woodfin A, Voisin MB, Nourshargh S. PECAM‐1: A multi‐functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 27: 2514‐2523, 2007.
 622.Wright WS, Harris NR. Ozagrel attenuates early streptozotocin‐induced constriction of arterioles in the mouse retina. Exp Eye Res 86: 528‐536, 2008.
 623.Wright WS, McElhatten RM, Harris NR. Expression of thromboxane synthase and the thromboxane‐prostanoid receptor in the mouse and rat retina. Exp Eye Res 89: 532‐537, 2009.
 624.Wright WS, McElhatten RM, Harris NR. Increase in retinal hypoxia‐inducible factor‐2alpha, but not hypoxia, early in the progression of diabetes in the rat. Exp Eye Res 93: 437‐441, 2011.
 625.Wright WS, McElhatten RM, Messina JE, Harris NR. Hypoxia and the expression of HIF‐1alpha and HIF‐2alpha in the retina of streptozotocin‐injected mice and rats. Exp Eye Res 90: 405‐412, 2010.
 626.Wright WS, Messina JE, Harris NR. Attenuation of diabetes‐induced retinal vasoconstriction by a thromboxane receptor antagonist. Exp Eye Res 88: 106‐112, 2009.
 627.Wright WS, Yadav AS, McElhatten RM, Harris NR. Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse. Exp Eye Res 98: 9‐15, 2012.
 628.Wu D, Peng F, Zhang B, Ingram AJ, Kelly DJ, Gilbert RE, Gao B, Krepinsky JC. PKC‐beta1 mediates glucose‐induced Akt activation and TGF‐beta1 upregulation in mesangial cells. J Am Soc Nephrol 20: 554‐566, 2009.
 629.Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol‐protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122‐1129, 1994.
 630.Xu Z, Tong C, Eisenach JC. Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology 85: 107‐111, 1996.
 631.Yadav AS, Harris NR. Effect of tempol on diabetes‐induced decreases in retinal blood flow in the mouse. Curr Eye Res 36: 456‐461, 2011.
 632.Yam JC, Kwok AK. Update on the treatment of diabetic retinopathy. Hong Kong Med J 13: 46‐60, 2007.
 633.Yamamoto R, Bredt DS, Snyder SH, Stone RA. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience 54: 189‐200, 1993.
 634.Yamanishi S, Katsumura K, Kobayashi T, Puro DG. Extracellular lactate as a dynamic vasoactive signal in the rat retinal microvasculature. Am J Physiol Heart Circ Physiol 290: H925‐H934, 2006.
 635.Yamashiro K, Tsujikawa A, Ishida S, Usui T, Kaji Y, Honda Y, Ogura Y, Adamis AP. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood‐retinal barrier breakdown. Am J Pathol 163: 253‐259, 2003.
 636.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411‐415, 1988.
 637.Yao K, Tschudi M, Flammer J, Lüscher TF. Endothelium‐dependent regulation of vascular tone of the porcine ophthalmic artery. Invest Ophthalmol Vis Sci 32: 1791‐1798, 1991.
 638.Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35: 556‐564, 2012.
 639.Ye XD, Laties AM, Stone RA. Peptidergic innervation of the retinal vasculature and optic nerve head. Invest Ophthalmol Vis Sci 31: 1731‐1737, 1990.
 640.Yeagle PL, editor. Membrane transport, Chapter 13. In: The Membranes of Cells (3rd ed). Boston, MA: Academic Press, 2016, p. 335‐378.
 641.Yoshida S, Yoshida A, Ishibashi T. Induction of IL‐8, MCP‐1, and bFGF by TNF‐alpha in retinal glial cells: Implications for retinal neovascularization during post‐ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 242: 409‐413, 2004.
 642.Yoshioka T, Nagaoka T, Song Y, Yokota H, Tani T, Yoshida A. Role of neuronal nitric oxide synthase in regulating retinal blood flow during flicker‐induced hyperemia in cats. Invest Ophthalmol Vis Sci 56: 3113‐3120, 2015.
 643.Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20: 175‐208, 2001.
 644.Yu DY, Cringle SJ. Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas. Comp Biochem Physiol A Mol Integr Physiol 132: 47‐52, 2002.
 645.Yu DY, Cringle SJ. Oxygen distribution in the mouse retina. Invest Ophthalmol Vis Sci 47: 1109‐1112, 2006.
 646.Yu DY, Cringle SJ, Alder VA, Su EN. Intraretinal oxygen distribution in rats as a function of systemic blood pressure. Am J Physiol 267: H2498‐H2507, 1994.
 647.Yu DY, Cringle SJ, Alder VA, Su EN, Yu PK. Intraretinal oxygen distribution and choroidal regulation in the avascular retina of guinea pigs. Am J Physiol 270: H965‐H973, 1996.
 648.Yu DY, Cringle SJ, Yu PK, Su EN. Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci 48: 2290‐2296, 2007.
 649.Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49: 732‐742, 2008.
 650.Zhang K, Ferreyra HA, Grob S, Bedell M, Zhang JJ. Diabetic retinopathy: Genetics and etiologic mechanisms, Chapter 46. In: Ryan SJ, Schachat AP, Sadda S, editors. Retina (5th ed). London: W.B. Saunders, 2013, Vol.2, p. 925‐939.
 651.Zhang W, Chen S, Zhang Z, Wang C, Liu C. FAM3B mediates high glucose‐induced vascular smooth muscle cell proliferation and migration via inhibition of miR‐322‐5p. Sci Rep 7: 2298, 2017.
 652.Zhang W, Yan H. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats. Exp Eye Res 105: 1‐8, 2012.
 653.Zhao S, Li T, Zheng B, Zheng Z. Nitric oxide synthase 3 (NOS3) 4b/a, T‐786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: A meta‐analysis. Ophthalmic Genet 33: 200‐207, 2012.
 654.Zhao Y, Liu J, Ten S, Zhang J, Yuan Y, Yu J, An X. Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage. Ren Fail 39: 698‐701, 2017.
 655.Zheng L, Du Y, Miller C, Gubitosi‐Klug R, Ball S, Berkowitz BA, Kern TS. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin‐induced diabetes. Diabetologia 50: 1987‐1996, 2007.
 656.Zheng L, Szabo C, Kern TS. Poly(ADP‐ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor‐kappaB. Diabetes 53: 2960‐2967, 2004.
 657.Zhu Y, Park TS, Gidday JM. Mechanisms of hyperoxia‐induced reductions in retinal blood flow in newborn pig. Exp Eye Res 67: 357‐369, 1998.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Retinal Physiology and Circulation: Effect of Diabetes
 

How to Cite

William S. Wright, Randa S. Eshaq, Minsup Lee, Gaganpreet Kaur, Norman R. Harris. Retinal Physiology and Circulation: Effect of Diabetes. Compr Physiol 2020, 10: 933-974. doi: 10.1002/cphy.c190021